# Feedback

comment:
The forward and back buttons are out of alignment


comment:
The forward and back buttons are out of alignmen


comment:
I agree with DE on removing the slide fuel cost competitiveness". Agree with IK that the chart and the lines used to lead to this graphs are not aligned i.e. the word gas market application is confusing as it could mean application segment which leads to my expectation to see the demand growth by segment in the charts. However, The increasing gas demand by region is impactful to highlight that not only the supply increase but the demand does too.


comment:
I agree with CWH comments for clarity in 1st paragraph. Also, would like to suggest reconsidering changing "drive it off the car lot" to something else...cars that are private party sales also depreciate. Not a "must," but worth considering.


comment:
Make sure all ICFs are capitalized: Trial-level ICFs, Site-level ICFS, Master ICFs, Country-level ICFS, etc.


comment:
Thought - Refer to Guaranteed Auto Protection instead of GAP -- especially in this example where the product is being introduced to the member.

Suggestion:  In both employee statements, he mentions "if the vehicle is totaled", could we include "stolen" as well?


comment:
Including a list of all vehicles that "may" be eligible may not be ideal, despite the note to refer to their product card. Rather than listing all possible eligible collateral, consider indicating that "In addition to private passenger autos and trucks, you may be able to offer GAP on other collateral types. Refer to your GAP Program Reference card for eligible collateral types at your financial institution.


comment:
Please change feature to "Waives Deficiency Balance"

On the 2nd benefit statement, I would remove "and not added to any future loans."  Just because a member has to add the deficiency balance to another loan, doesn't mean their credit will get damaged


comment:
I do not like this definition, and it does not match up with the product reference card we advise them to have handy. I do not have a suggested revision...hoping the group can come up with something together that reads better.


comment:
Suggestion regarding the lender's last statement...
"No, GAP enhances your current insurance coverage. Without it, if your vehicle is totaled or stolen, you will be responsible for any balance remaining on your loan after your insurance company settlement. This could impact your credit rating, and your ability to finance your next vehicle."


comment:
Edits for Develop Master Informed consent map:  remove the line "The Develop Master Informed Consent Process begins once the trial-level...." from audio and transcipt. Same process map, first milestone, please use the language provided from Lilly in the word document without the bullets. In the third milestone, in second sentence delete second instance of "site manager" and capitalize Site Manager.


comment:
I do not like to use the terminology "deficiency balance" in instances of customer communication...that is not termininlogy the average consumer is familiar with. Suggest "Helps eliminate responsiblity for remaining balance."  I agree with previous comments, as well.


comment:
PROCESS MAP EDIT Develop Master site informed consent: I never got the next button to move forward.


comment:
The second benefit statement says "family is covered", which I guess they are indirectly.  Perhaps "It provides peace of mind knowing that your loan balance will be protected in the event...


comment:
May be a picky thing, but this profile uses far too many contractions. May change some of the "she's" to "she is" and "she has."


comment:
EDITS FOR PROCESS MAP DEVELOP SITE INFORMED CONSENT: Capitalize Site Manager in first milestone. Do global check to make sure roles are capitalized.


comment:
Third milestone, the last bullet tab it under the third bullet.


comment:
1st statement: change policy to coverage...it is not a policy. And it is not "if something happens to the car." It is specific to "if the vehicle is totaled or stolen during the term of your loan."

2ns statement:  User vehicles do not depreciate "like new vehicles." "Used vehicles continue to depreciate, so it is possible...".  Again, suggest replacing "deficiency" with "remaining loan balance," and adding "totaled" in addition to stolen.

3rd statement: I think "lost" was intended to be "low."


comment:
I am not getting why all of these "Features" would not mean something to this customer based on her profile. one of them do not appear to be profile specific.


comment:
Please add "Totaled" to the feature.

GAP may not "eliminate" all out-of pocket expenses. Suggest "GAP can help eliminate..."

I agree with CWH that the "family protected" benefit isn't the best. Replace as suggested.

I also agree with TW, the instructions of what I am supposed to do here are not clear.


comment:
Can we rephrase the conversation line? I feel  The flow with the previous slide is not good as these 2 become the questions out of the blue.  Is it better to make it like, when is gas to be considered/ offered/ or better than diesel? -> low emission requirement and then create a separate page for the store/transport/maintain quality


comment:
Line 5 of Lilly's edits asks to make the incorrect feedback generic.


comment:
Provide consenting guidance popup, missing a space after first sentence.


comment:
Add the word map after process in first bullet


comment:
Also suggest capitalizing the bulleted sentences in the transcript.


comment:
Suggest separating the directional text from the standard text.


comment:
Third bullet point: You refer to "the site" at the start of the bullet and then refer to "the sites" at the end. Suggest using one or the other.


comment:
CreatingClinPharm Process Map: Check the transcript. I think there is an extra "process" in the third or fourth sentence.


comment:
CreatingClinPharm Process Map, Second Popup, First Bullet: It appears there is an extra space after the first "ICFs".


comment:
CreatingClinPharm, Second Process Map, Third Milestone: "Site Manager" is mentioned twice - should one of the instances be removed? Also, I believe Site Manager should be capitalized.


comment:
CreatingClinPharm, Second Process Map: The Next button would not appear for me on this screen.


comment:
CreatingClinPharm, Third Map, Second Milestone: Site Manager should be capitalized. May want to check all Lilly titles throughout the course to ensure they are capitalized.


comment:
CreatingClinPharm, Third Process Map, Third Milestone: Suggest making the "Once approved..." text not a bullet but keep the "Records..." text as a bullet underneath.


comment:
Just a reminder to double check Lilly titles on this screen and throughout the course to ensure they are capitalized.


comment:
Have we decided on customers rather than borrowers? I am suggesting borrowers.
Change wording to "what most insurance companies say your car is worth" (from what most insurance say your car is worth)


comment:
Transcript - add oxford comma to sentence "In this course...."


comment:
Incorrect Feedback, Second Sentence: Suggest removing "reviews"


comment:
first sentence on-screen - any way to condense it? It is a lot of words. Maybe "The CDIO collaborates with the study teams...to improve/optimize (choose 1)..."


comment:
Provide Necessary Resources Popup, Second Paragraph, First Sentence: Add "the" between "Ensure" and "TPO"


comment:
Agree with KWE.  I am not sure of the origin of this definition but it does not match what we currently use.  I am also personally not comfortable with describing GAP as an "enhancement".


comment:
milestone 1: first sentence super long. Recommend removing "for the trial" from end of first sentence. Plus any other modifications you can make to shorten it up, if any


comment:
first bullet edit "The SRR Rep facilitates the selection..."


comment:
third bullet: change verb tense of determines to determine since the SRR rep + study team is multiple people


comment:
Would suggest using borrowers throughout instead of customers since we could potentially us these modules at banks, credit unions, finance co., etc


comment:
Pls. check with SME on the following. I'm not sure whether it's really matter. 

1.Do we want to include the acceptable range of methane no. In the email, it just mentions about 0 and 100. Maybe it's a good idea to advise the range of good methane no. and any watch out or suggestion to do if it's lower than our products capabilities
 
2.Do we want to mention that pls. contact SAE if need help for fuel analysis? 

3.Do we want to highlight the fact that our genset can handle lower methane no. than competitors.


comment:
If you select "Yes" for the first question, it does not allow you to replay. Suggest adding the replay button to this option as well.


comment:
Ignore my previous comment. I didn't understand how the activity worked. :P


comment:
Maybe an extra space before the first and second sentence in the third paragraph


comment:
couldn't copy edit the top 2-3 roles because they disappeared when I hovered over them


comment:
Pictures in the first and second popups seem blurry. However, if you don't have easy access to new pictures, don't worry about changing them. :)


comment:
study mgr popup, 1st bullet: add "the" after consults


comment:
correct feedback: change "a" to "an" in 1st sentence


comment:
correct feedback: change "a" to "an in last sentence


comment:
transcript: extra space between enrollment and Additionally


comment:
Suggest possibly formatting this question to be like the other two (the description text is purple).


comment:
Popup: Suggest adding "study" before "participants"


comment:
Including specific eligible collateral, max terms and amounts, and coverage limitations as part of this animation is not advisable, as those can vary by client...even vary from what is allowed by their master policy. Really need to stick to generic statements, driving learner to the product cards for specifics.


comment:
Picky item, but please replace "lots" with "a lot."


comment:
I agree with previous comments. Also, example should be auto/truck...not all clients offer GAP on motorcycles.


comment:
The verbiage needs work.  Fore example, "if something happens" needs to be more specific to total loss and theft. And it doesn't cover "any difference," as some differences may be due to exclusions (late fees, interest accrual after loss, overloan, etc.


comment:
Second bullet: add 'is' after Enrollment manager-before the word responsible


comment:
I don't like these graphics at all. Plus I don't like using leica image in there. Were there any other concepts? I can't seem to move the lens.


comment:
Is it possible to change from real people to animation instead of the real images?


comment:
I don't get this guy Carey. It does not relate/translate well. Can we use animation instead of real people?


comment:
Competition - I don't want to use that graphic. We should only compare Leica and Philips.


comment:
I am wondering if this slide should follow the definition slide.  Feels odd going through all the details of the product card before even defining the product.


comment:
I'm sorry, my comments on the previous slide belong here.  Feel the definition slide should come before this one.


comment:
Agree this definition is not practical.  Let's re-define as a group.


comment:
The definition on the Good Job pop-out is good.  Perhaps we go with that.


comment:
We need the offer to have more urgency and a stronger value proposition in the first part.  Also in the second response, we should never have the word "NO" start a sentence.  That is poor professional communication and doesn't build a sense of helpfulness.


comment:
Might be more powerful to state it may eliminate the remaining loan balance which can be stressful to deal with, especially on a vehicle you no longer have.  Need to elicit more feeling and pain points.


comment:
Agree with KWE -- this one needs quite a bit of grammar clean-up. Should sound professional.


comment:
Totally confused by these "features."  None of them are worded in a way that we would want our clients to describe them.  And agree with KWE that there isn't one that stands out.  It took me many tries to choose the correct answers.  Let's come up with some new features that are clear and strong (right or wrong).


comment:
The "features" in the gray boxes are not even features.  Need fixed.  I struggled with the answers on this one too.


comment:
Not sure this is a strong enough concern to use as an example.  There are other more common concerns that would be a better fit for this slide and the previous.


comment:
Confused why they are concerned about the deductible and how that even comes up.  I'm not sure that is the best example of concerns.


comment:
Not sure the 60-day free look is ever an exciting feature.  Wouldn't use this as a best-fit feature in this example.  Perhaps the low cost is a better hot button - it barely affects the payment amount when financed into the loan.


comment:
Can we add slides that are linked by clicking on a qualifying button?  For example, ask them to click on the button of the state your FI is in -- and maybe that links them to a slide that explains the generic basics about the GAP that is in those states.  This would provide for GAP Advantage states to have a blurb about the GAP Advantage benefit.  Of course we'd want them to refer to their product cards for specific LTV %, # missed payments, etc. but we can at least talk about why they are what they are.


comment:
Feels weird to tell them to talk to their Allied rep in a slide.  This is just a basic training.  Hopefully they will be coming to our F2F training and we can chat there. I also like to enable and encourage them to talk to their coaches, but maybe that's just me.


comment:
Agree with all comments.  Needs cleaned up and a more clear answer.


comment:
Still answered it wrong even going through this twice.  We should have stronger responses so it is evident which is best and at the highest level of professional offering.  We want the learners to start off on the right foot with strong examples so they can be confident and have success.  These feel only so-so to me.


comment:
Is there a way to work in a reminder that there are other lean burn genset training modules to look out for?


comment:
I am not in favour of referring to the the classroom training as these sessions are currently not being held on a regular basis.


comment:
When getting the wrong answer the text box states that the user is 'still in the post sale stage' I guess that's the last stage so will never get any further so best to drop the word 'still' from the above sentence.


comment:
If this to be a global module covering NA and ROW then we should show both ranges of products not just NA products


comment:
I didn't have to download the recourse before clicking next, hence I didn't read it until I got the wrong answers, suspect others will do the same


comment:
Comments made by others about explaining why the tools are correct or not correct would be very beneficial and applies to all three customers


comment:
The controller image on this page needs revising, I will send a new image, it is similar but the one shown at the moment does not get fitted to the set.


comment:
The image here needs to be changed for a large genset (QSK95) with perhaps another couple of smaller ones from the current range in the forground


comment:
Remove WWID and associated text/functionality from splash screen.


comment:
change the name of this screen Managing Site Information Process Overview (and menu title)


comment:
Sorry - I didn't notice this until I looked at the "Managing Site Information" course.  On the introduction screen, after the audio narration plays, please have the following text appear on the screen.  This should occur for all courses (will let Leo know).

"Below are the milestones in the Managing Site Information process.  

Please Click(bold) the xxxx (insert first title of milestone - in bold text)milestone (in bold) to learn what happens during the xxx (insert name) process.


comment:
Sorry - I didn't notice this until I looked at the "Managing Site Information" course.  On the introduction screen, after the audio narration plays, please have the following text appear on the screen.  This should occur for all courses (will let Leo know).

"Below are the milestones in the xxx (insert name) process.  

Please Click(bold) the xxxx (insert first title of milestone - in bold text)milestone (in bold) to learn what happens during the xxx (insert name) process.


comment:
in the comment above, 4th sentence, remove Managing Site Information, should be the name of this process (Develop Master Informed Consent).


comment:
design question - what is the significance of part of the icon turning red?  I don't get why 3 of these are checked and the2nd is a double arrow?  are these needed, since the color of the icon indicates which have been "clicked?"


comment:
Consider capitalizing "Marine Market" where possible.


comment:
I need to put a placeholder screen in here for this.


comment:
The blinking icons are obnoxious. I need to change. What do you think about the transcript?


comment:
The font in this entire training course should be considered for change.  The letters are too close to each other within the words and so after reading a slide or two, a person may have issues with focus causing headaches, etc.


comment:
Put the note about repeated activity on the first page so they don't need to continue through all of these screens.


comment:
Need to replace System images with ones with no white background.


comment:
Fix Begin your training icon. Isn't linked currently.


comment:
Need to add titles/sub titles for the competitor bio screens.


comment:
Is it clear to the person taking the course (from this page) that these "Features and Benefits" that they are getting ready to learn about are for the QSK95 Marine or are they for the QSK95?  The prior section was discussing both.
I think title should read "Features and Benefits of the QSK95 Marine".


comment:
This section needs more info, otherwise the client will get stuck in the try again circle of life.


comment:
Change electromagnifier to candle in the directions.


comment:
Need to add notes to this screen and let the learner's advance.


comment:
Need a note to Roche here explaining that if they get less than 80% they will fail and be given resources to help them pass the course. Resources will include the previous blood bank course.


comment:
Please update the QSK95 Marine lower RPM range.
Should be 1500 RPM, not 1400 RPM.


comment:
Change this to "...the next phase in Operation: Reveal. This course focuses on two competitors-Abbott and Grifols."


comment:
"...CBB has an increased need for safe blood..."


comment:
"...recent bat-related infection also drives this need."


comment:
Need to introduce the transcript somewhere.


comment:
Remove the commas in the last sentence between the words "different, and" also between the words "than, a".
Add comma between "traditional, downstream".


comment:
Here's a question for this one: How many assays can labs load on the Panther System at one time? 

Answers: 2, 4, 6, 8 (4 is correct)

Feedback: Labs can only load up to 4 assays on the Panther System at one time.


comment:
"If you want to make a case for Roche's panels, you need to know something about our competitors' panels. Next, you'll see a list of competitor assays and performance metrics. Help me decide which performance metric belongs to each assay."


comment:
Let's remove the ipad. It's too spyish. A standard feedback box will work unless we feel like coming up with something vampirish.


comment:
Here's a question: "How quickly can Abbott customers perform STAT testing?"
Answers: 10-20 minutes, 20-32 minutes, 15-43 minutes (last one is correct. 
Feedback: "At best, Abbott customers can perform STAT testing in 15 minutes, but it could be as long as 43 minutes for some tests."


comment:
I think we can hide the rest of the screens for this activity for DP. We'll write the rest of it at Alpha.


comment:
Would a possible solution to having so much info be to make a bullet point for each chart listing the most important data from it, then have the charts in the resource section?


comment:
We need a note asking whether this is a conversation about competitors (as in Reveal 1 & 2) or a series of questions about this customer (as in the first blood bank course).


comment:
Let's replace with a real Grifols statement: "The Panther system may not always provide random access capability, because only four assays can be loaded at once and requires frequent calibrations."

Pick a few key words as the draggers.


comment:
We need something other than Zorro. He lives in Mexico.


comment:
This should be Barcelona, Spain or just Spain since that's what the clue said.


comment:
In the Note:  
Please change 'Assent' to 'Assent(s)


comment:
Can we add 'required tool' after 'Notification of Approved Records'?


comment:
The Note duplicates the wording immediately above.


comment:
The picture of the pen is covering up part of the word 'master'


comment:
When I clicked on this link, it opened up a new tab to the ICF collaboration site as well as going to the screenshot of the tracking log.


comment:
Title of the tracking log should be bolded


comment:
Add 'required tool' after 'Notification of Approved Records'.


comment:
I understand with the branching that we cannot disable the Next button but I think this could be confusing to users. 
I think we need to amend the wording in the purple bar to something like 'Do not click the Next button. Instead click here to review another revised screen'.


comment:
At Site-level - can we change informs to inform


comment:
Add 'required tool' after the tool title


comment:
The change here is to the tool title in the question and answer, however, to see the answer, user would have to click submit which then takes them to continue button and the next knowledge check.  You can't see the changed answer and then click on the button to go to the next revised screen.


comment:
Is there no way we can have a different summary slide for completion of the revised screens? This doesn't make sense for the abbreviated training on revisions only.


comment:
The other option is to have the end of the revisions course go to the Questions screen rather than the Wrap Up screen.


comment:
This is probably leftover colors from the old course, but Cheryl and Dewi thought the red and green was too Christmas-y. Might not matter with an international audience. Thoughts?


comment:
Does everyone in this audience know what RBSS is? Is that a common acronym or something we use at BLP? We could have it say Operation: REVEAL Blood Screening


comment:
Can we make the background image a hospital? I know we aren't at final graphics here, but it might help get into the set up of the story.


comment:
We switched to blue buttons and icons on the pop-up. Should the green ones of the previous two screens have been blue?


comment:
I remember that she needs to be a Roche Rep to make this work. But would she also be a nurse then?


comment:
Replace this first question with placeholder content. Add a note telling Roche that they can use the menu to navigate to the grading screen to skip the 20 placeholder questions, as that might be annoying.


comment:
Is CBB a common abbreviation for Central Blood Bank?


comment:
"...their assignment focuses on finding Dr. Blut,...."


comment:
We may not want to intro Veinovia times here since we aren't sure it will be the resource for the elearning. It might just be linked as a resource course summary. I don't want to promise something we aren't 100% sure of yet. We may need to chat.


comment:
Can we make the orange bar move faster so there isn't tons of dead space and it goes to the end?
 I know that is nit picky for a DP but I wonder if they will call it out since it is the one they are supposed to be seeing as fully programmed.


comment:
I'm not sure that the photo says 'loan officer' to me.  She's dressed appropriately but it might be better to find a businessman/businesswoman at a desk?


comment:
Need to add the word modular after 8000. The full name is cobas® 8000 modular analyzer series with cobas bolded.


comment:
1st paragraph - And it's value...  it's should be its - no '


comment:
Spacing on of the icons in the Icons section seems a little off.


comment:
Change What's GAP to What is GAP? and What's It's Value to What is GAP's Value or GAP's Value.  Don't like the contractions.


comment:
In the Icon section, change to notifies instead of Notifies in the Roche Diagnostics University Tool description.


comment:
I'm not sure about the photo and how it fits in to a module on GAP.  Maybe it should be a photo of an office with a desk and computer on it or a photo that looks more like a bank/credit union?  Note - on a previous slide I indicated I didn't like all the contractions.  In this case I don't mind Let's.  It just seemed awkward in the previous situation.  I think saying Let us see... in this situation would be awkward, so the contraction works.  Hope that makes sense.


comment:
In the blue header it says 'What's GAP?' and down below it says 'What is GAP'.  'What is GAP' is better.  The one in the blue header should be changed to match.


comment:
Add module after cobas c 502, cobas c 702 and cobas e 801 for 1st bullet answer.


comment:
Should the color of the text directions match the color of the logo?


comment:
Let's choose an age for Lakeisha instead of saying she's around an age.  How about Lakeisha is 25 and has been out of college for a few years.  Do we need the sentence about her making all the decisions?  If we want to call attention to the fact that she's single, maybe we can just add that to the sentence about her age?  Lakeisha is single and 25... or add it to the following paragraph.  She's single and is pretty sure....?


comment:
The speech bubbles load very quickly.  Maybe they can be slowed down so it's more consistent with actual conversation?


comment:
Question 4 - change cobas 8000 analyzer to cobas 8000 modular analzyer series with cobas bolded.


comment:
change volumes in 1st bullet, 3rd subbullet to the following:
SmpCln 1 - 2000 µL
SysClean - 2000 µL
Activator - 2000 µL


comment:
In the first sentence - consent should have a capital C in the name of the Master process map.


comment:
Remove . after ISE module in 1st bullet>2nd subbullet


comment:
Add change to the following in the activity:
Unload and Load Reagents for ISE module
Unload and Load Reagents and Consumables  cobas c 502 module CellCln1 (NaOH-D)
Perform Reagent Detergent Volume Reset-lSE 1 IS and cobas c 502 module Cell Cln1


comment:
Change question 6 to "On which modules do you prime reagents?" Remove two since 3 modules are listed as the answer.


comment:
Why does the first bullet state if a Master ICF was not developed?  A site-level ICF would be created whether or not a Master ICF was created.


comment:
Statement under objectives is not correct. Change to "Complete the following training with your group. Tell participants to take notes in their checklists."


comment:
Statement under Objectives needs to be modified. Please change to "Complete the following training with your group. Tell participants to take notes in their checklists."


comment:
Please change the statement under Objectives to "Complete the following training with your group. Tell participants to take notes in their checklists."


comment:
Ignore my edit regarding the statement. I meant to record the edit for the Daily Maintenance page.


comment:
Remove . in sub bullets 2 and 3 in the 2nd bullet.


comment:
Change statement under Objectives to "Complete the following training with your group. Tell participants to take notes in their checklists."


comment:
Can we put 'if applicable' after regulatory authorities? Not all RAs require ICFs to be submitted.
The second sentence of that bullet then needs a clarifier - it may be approved internally prior to submission.  
Second bullet - Confirms that any requested changes meet Lilly, ICH GCP and local requirements.


comment:
The photo, while fine on the previous slide, is backward here so she's driving from the wrong side of the car.  May need to choose a different photo.  First paragraph - agreed on the contraction.  Amber IS a single mom...  I think it could also use an 'a' before daughter.  ...with an infant son and a daughter in elementary school.  I'm okay with the contraction in the first sentence of the second paragraph but think that she should have 'a lot' of questions instead of lots.  The second sentence could just be 'She found a reliable used car in her price range that she's interested in purchasing.


comment:
Why is the second bullet talking about translation of trial-level consent documents?


comment:
change cobas e-flow process to cobas e flow process and bold cobas and e in the last bullet of "Demonstrate how to manually order and cancel calibrations and explain".


comment:
Would suggest to amend the last bullet to: Creates standard translations if translations are needed after the ICF has been approved.  Communication is in the next milestone.


comment:
change cobas e-flow to cobas e flow with cobas and e bolded.


comment:
Can we add a clarifier to the first bullet:
If Lilly rather than the site submitted the ICFs to.........


comment:
For Back Up and Delete Data and Back Up and Delete Print History, there seems to be extra space. There is more space above them than the other topics on the page.


comment:
The footprint pop up covers the continue instructions.


comment:
Do we need a note that the images will be updated to take off Hologic? I see the instrument is rebranded but the pop ups aren't yet.


comment:
Change section header in the blue to What is GAP's Value or GAP's Value - whatever was decided upon earlier.


comment:
Was this course always in this order? It seems weird to have the background and purpose of ICFs after we have talked about the master and site ICF processes....


comment:
Can we hide these and just say the activity repeats for Abbott?


comment:
The wording in the purple box is not accurate.  In some countries, it would be the master (country-level) ICF that is submitted to the RA/ERB and which they could request changes to.


comment:
Question 4 - change used QC details to Used QC details for consistency.


comment:
Second bullet.  Can we add 'if applicable' after Regulatory Authorities?  Not all countries require submission of ICFs to the RA.


comment:
With the changes to how the processes are represented in the full course, I think we may need to look at the order of slides - the flow felt disjointed to me.


comment:
Ha, I'm dumb but I was looking for the envelope. I just thought this was a white box.


comment:
At the conclusion this screen still says welcome.


comment:
We need to reorder the menu so that the 4 categories here are the main topics and everything else falls as a sub and sub-sub category.


comment:
In chart for e 801 cleaning - Change Liquid Level Sensors Length of nozzles to Length of sensors.


comment:
You are talking about what Leanne sent for the design, right? Agreed.


comment:
Change "how does it work" to "how does GAP work"
Change "it's" to "its" where necessary...considering removing its' to "what is the value of GAP"

Consider removing all contractions


comment:
Agree with all - consider removing all contractions to keep it professional; How Does GAP Work? What is the Value of GAP?
Rather than show a catastrophic photo of a car accident (which frightens borrowers against purchasing, consider a tree on the car from a storm, or perhaps a car with less damage, which could still be deemed a total loss)


comment:
Agree KWE!  Otherwise, I like the interactive exercise...


comment:
"LaKeisha is around 25" - change to LaKeisha is 25"
LaKeisha  (and other borrowers) do not tend to use vernacular such as "secondary insurance" (it is the first I am hearing anyone think such) - perhaps change it to "I believe I already have this type of coverage through my insurance agent"


comment:
LaKeisha  (and other borrowers) do not tend to use vernacular such as "secondary insurance" (it is the first I am hearing anyone think such) - perhaps change it to "I believe I already have this type of coverage through my insurance agent"


comment:
Agree with all...contraction overload (I personally find them unprofessional)
"Now that Amber is on her own, she has lots of questions" - change to "Now that Amber is on her own, she has a lot of questions"


comment:
Features for Amber - please add to option #2 "if the car is deemed a total loss or if it is stolen"


comment:
HA, agreed. I'm stuck in the circle of try again! I got confused if I was looking at 1 question on a loop or if I was doing question 2 yet....


comment:
Benefits for Amber - unsure how to complete this exercise as I tried all 4 and they were incorrect...unable to move to the next screen


comment:
The screen after the clue is revealed might be a good time to add, if you need a blood break, go ahead. You'll want to be fresh for the next section...


comment:
Add a note that the guru game isn't ready yet.


comment:
Update cobas e 801 Liquid Level Sensors How? to Length of sensors.


comment:
after verbal intro and you click on "R&R Strategy Completed", it places a red check mark on the next milestone of "R&R Master Content Completed".  this is not logical as the learner has not completed that milestone yet.


comment:
same issue as prev screen...when you click on "R&R Master Content Completed", it places a red check mark on the next milestone of "R&R Country-specific  Content Completed".  this is not logical as the learner has not completed that milestone yet.


comment:
when you hover over the "R&R Country-specific Content Completed" box to continue, there are words overlaying each other and appearing garbled


comment:
same issue with red checkmark appearing on next milestone before its actually completed.


comment:
same issue with red check mark appearing prior to completion of milestone


comment:
should the first link actually take you to BWL map?  it currently does not but the other 2 links do take learner to specific document.


comment:
In the planner, under Saturday, it should match the actual agenda which is "Write Your Story"?.


comment:
These statements need to be in the video per our discussion last time.


comment:
The title instruction doesn't match the actual content below. We need to change this opening section.


comment:
Proposed change - "The Service Support sub-function is globally-connected to help customers by answering inquiries quickly and providing solutions."


comment:
It should be "Service Technical Training" in the title box button.


comment:
In the title instruction, should it be "how you fit into the organization" or "function"?


comment:
It should be "Service Technical Training".


comment:
Should we say "disappointing experience" up front? It sets up a negative tone from the beginning.


comment:
"It is Thursday: time to talk about...." - this does NOT match the content on Thursday which is Customers are Priority. Need to change.


comment:
Consider adding a statistic instead of using the words "a lot".  Did you know that the average new car will depreciates about 30% in its first year.  And it's value continues....


comment:
Instead of asking "have you considered GAP?"  replace with "How familiar are you with GAP?"


comment:
Confusing slide.  Instructions are not clear.


comment:
The Exit icons do not match from the screen to the Menu.


comment:
I thought we discussed this before, but some clients will not have speakers available to them. Can we have something they click on if they don't have sound where it will provide text of what is being said?


comment:
Resources - including your product card. We will need to provide a link to iQQ where the learner can access their specific product card. Would provide link along with instructions on where to find it.


comment:
Do not put periods at the end of bullets unless they are complete sentences


comment:
I thought there were comments on this earlier, but I don't see them now. We should not say ..."problem with traditional insurance coverage" It isn't a problem with auto insurance... could we say, helps them recognize how GAP can provide value to them? Where they may need GAP?


comment:
I suggest we stay away from using year for vehicle if possible... this could potentially date the materials quicker. Could we say...decided to trade in her 8 year old vehicle for a new SUV....or something like that?


comment:
When you click the back arrow, you go forward


comment:
On the pop-outs, maybe specify that the user needs to click the forward arrow to continue?


comment:
I don't like the word "enhance" to describe its relationship to insurance. It is not an insurance product. I'd prefer something like "supplements" instead.


comment:
Another instance of the "back" arrow moving forward. If the intent is not to allow to go back, should remove the back arrow or fix.


comment:
Another instance of back arrow moving presentation forward.


comment:
The "correct" answers need to tie directly to information discussed in previous slides if truly using this as a test of understanding of the value. This might already be the intent, but thought I'd mention.


comment:
Just my preference, but to limit clicks, this screen should be OK to have a "click here to exit course" button instead of having to go to the menu. Or, automatically exit the course when the cert is printed.


comment:
This page is missing the ID number and version


comment:
The feedback tool wouldn't open on the opening screen. Edits for that screen: Transcript button not working. Add line "Below are the names..." above the instruction text.


comment:
In second sentence remove dash before qualification.


comment:
First sentence:  We have been receiving many question about the other types of change forms (CT Material, Local Lab and EMR) since these are new yet not seen in the TF system which is causing confusion.  Could we add the following in () after site processes?  (e.g., change in CT Material destruction)


comment:
Here I would suggest What's it's Value, before "How Does it work".  My sense is that lenders want to know the "Why" before the "How"


comment:
to my earlier comment I think we should add one of the other types of changes because CDCs and COPMs think they only have the PI & Location change forms available and since that is what we know that seems to be all we are including in our training-just a thought otherwise it looks to the learner we only have the same forms as before PI, Location & Trial change forms


comment:
In order to fully examine this phase I would have to see the feature and benefits for each scenario.


comment:
We must stress that this is broad definition of eligible collateral and that the lender needs to check program card for specific information on their FI's GAP program


comment:
since we use destruction of CT material later in the module can we add a different example in ()?  like (e.g. implementation of EMR for clinical research)


comment:
the "Visit another revised screen" disappears when you click on the milestone descriptions,  need to somehow make it so it people can see it.


comment:
update text in purple button based on what we did for the other branched course


comment:
I don't think appropriateness is the right word here.  It is just to ensure that the new PI is qualified by education, training and experience


comment:
When you hit the next button you get sent into the whole course.  I think the next button needs removed if you have already taken course


comment:
Visit another revised screen ends up going behind the lady when you open up the boxes.  The next button should not appear if you are just reviewing changes


comment:
Need to update this with same exit language as the other branching course.


comment:
Same issue that when you open the boxes, the see next revised screen is hidden and the next button should not be available when you have already taken course


comment:
Why is the button called different changes - is this in existing course?  We should use something like common types of changes?


comment:
It is not transferred to IMPACT - that implies it is systematically transferred.  I would take this all out and say that required site information must be entered into IMPACT.


comment:
when I didn't click on the "I have completed the course before" I still saw the "Visit another revised screen" button, which I shouldn't see for the full course.


comment:
none of the options is correct - feedback needs to be corrected  (Plan for clinical trial production) to show this is the correct option


comment:
none of the feedback from the options shows a correct response.  need to change the feedback on "Ship Lab kits to sites" to give feedback on this as the correct response.


comment:
the feedback on the correct response (which now reads as incorrect) should read: You selected the correct (incorrect after 2nd wrong try) response! Shipping Lab Kits is not a key task for the Enrollment Manager in this process.  Delete the rest of the feedback.


comment:
Feedback for the correct (or 2nd incorrect try) should read "Correct" or Incorrect" (2nd incorrect try) Planning for clinical trial production is a key task in the process.  Delete the 2nd sentence.


comment:
menu buttons got mis-aligned... stupid SL :(


comment:
couple things: i was not able to add feedback to the first screen in this module with the new process map.

for that one: i was unable to access CC. you also need to change the icon in the buttons to grayscale just on the disabled state.


comment:
on return to this screen, after you have already completed it, aren't we making Next and the first milestone active?


comment:
Per the process walkthrough draft, there is missing text after the first sentence. Please add this text, "These plans must be documented."


comment:
move instructions to be right after the text, not all the way at bottom


comment:
correction to added text - These plans should be (not must be) documented.


comment:
Probably not a surprise to you but the correct hotspot is off on this one as well.


comment:
I would suggest to mention that the list showed is not a restrictive list Study manager will notify to other groups and may consult other functions also.


comment:
2nd bullet: Suggestion: Site Mgr. processes, obtains and manages approvals/notifications from required.... 
NOT always an approval is necessary and only a notification is sent to ERBs or Competent Authority


comment:
Responsible for On-Site Activities, is this the CRA? I think we need to clarify.


comment:
For MQO, I suggest: The MQO representative is consulted by Study team throughout...


comment:
I understand Erin is the CRA. She would not be ensuing Lilly IMPACT has the information. The information migrates from CTMS and Lilly site manager ensure the information is in IMPACT


comment:
need to remove red icons for the new purple ones


comment:
extra space in 6th line before "logging" maybe


comment:
suggest removing "then" in "If I complete these tasks..." sentence


comment:
based on edit in line 14, do we need feasibility on here either?


comment:
Change directions to say Click > to continue.


comment:
Nice to Have - can we take a screen shot from each of the videos and insert them? Or at least change those boxes somehow so it's a little clearer their images?


comment:
the text edits didn't get made to this page. It also needs a 4th popup per slide 8 in script.


comment:
can we add a play button so it looks more like the placeholder we used in Pap Attack? (See Your Mission screen http://bottomlineperformance.com/clients/Ventana/CervicalCancer/PapAttack/DesignProof/story.html)


comment:
These popups need to be a lot bigger - needs to fit 4-5 bullets. If possible, can the region you clicked on stay highlighted.


comment:
change checks to some other visited state - maybe gray?


comment:
can you make it so the image stretches the full page? it looks odd with the 1/4" of white on the right and left.


comment:
I don't love the blue arrows. I don't think we need those on the menu since there's a visited state.


comment:
big 50% inaccurate should fade in last - right now it appears before text.


comment:
click next instructions like the other one


comment:
click next instructions like the otehr one


comment:
3rd bullet, The Enrollment Manager...works with(subject-verb agreement)


comment:
4th bullet -  I think this is the first use of PDO, if so need to spell out as "Primary Data Owner (PDO)"


comment:
the correction above from must to should is in the audio transcript


comment:
The following is the description/information for each of the date fields (No further info beyond this is necessary):



Investment Date:
Investment Date indicates the date the project was started or is programmed to start; equivalent to the date from the Project Start Form. 

The year from Investment Date will become the beginning from the Prior Years timeline. 


US LD:
US LD is the launch date for the US. 

The OnePager will generate a 10 year timeline following the Prior Years and starting to count from the earliest LD year whether from the US or CE.


CE LD:
CE LD is the launch date for the EMEA. 

The OnePager will generate a 10 year timeline following the Prior Years starting to count from the earliest LD year whether from the US or CE.


comment:
Please leave blank the ASP, Units and Sales for 2018 NAM so that they match the Business Case (NAM has no sales in 2018)


comment:
To elaborate on the empty space for NAM 2018; 
Yes, it's ok to leave it empty on the official SPMT =)


comment:
Please make the Sales numbers on the background look in the following format (which is the actual format of the OnePager):

2019
6,049,643	

2020
9,533,335	

2021
13,718,838	

2022
16,328,076	

2023
18,657,793


comment:
Once the excercise is completed, 
Please erase the Red text that says "The OP field is required" on year 2021, you can erase it by just pasting a square of the same gray color on top of it.
Tnx!


comment:
Please remove this question, as nothing happens if they do not assess the risks correctly on the OnePager. 

However, please keep the explanation of assesing the risks along with the IBL.

Risks are actually assesed into greater detail during the Business Review.


comment:
Well done!
This question does apply in this section,
Tnx!


comment:
Just remove the "adding APAC" scenario, please


comment:
Instead of the "adding missing APAC", please just add a text box saying something like:

"If you still need to enter more data into the OnePager, you can always save your progress and return later"


comment:
Instead of the excercise, show this view as something like this:

"NOTE: Under the P&L Impact tab, you can access and edit the region information you entered previously by clicking on <View P&L Values>"

Tnx!


comment:
Regarding IMPACT close out visit date, it´s important to check how it will be populated. In my understand the final version of the  business process for data exchange between sCMTS and IMPACT has not been finalized yet


comment:
enrollment is randomization to treatment or receipt of first treatment and is defined in the protocol.  Please update the first bullet so that it states "...pause screening, enrollment, and/or randomization..."


comment:
Since the box is mostly empty for "impact of change communicated milestone" it almost looks like something is missing.  Can the box be made smaller or the text repositioned to help?


comment:
I think "site related" should be hyphenated.  Appears twice in the "Trial-Level or Site Change Activities Completed" screen


comment:
I struggle with the title, "Trial-Level or Site Change Activities Completed"  Is this page for site changes at the Trial-Level and/or Site-Level?  If so, the title needs to change to include all of that, it will be long and wordy, but otherwise, it isn't comprehensive or clear.


comment:
Per the process walkthrough draft, insert the last sentence, "After all of the site close-out activities are performed, the site is officially closed"


comment:
3rd sentence after comment, "...all site early termination activities.."


comment:
The first sentence in the draft process walkthrough is missing - it's general enough that I think we can leave in - check with Laura.   The sentence reads, "This process begins when an active site is to be closed out."


comment:
1st bullet - change "discusses" to discuss"


comment:
Site Selected Popup: Suggest adding a comma after "qualified sites"


comment:
Suggest checking that Lilly titles are capitalized throughout the course.


comment:
Suggest unbolding and not underlining the period after "judgement based decision making framework"


comment:
Third Bullet: Suggest adding "the" before "clinical planning"


comment:
Final paragraph: Suggest changing "patients" to "study participants" and doing a global search to ensure patients does not appear anywhere else.


comment:
Last Text Box, Third Bullet: Suggest adding "the" before "clinical planning"


comment:
Should "they are" be "it is" in the first sentence?


comment:
Last Sentence in red popup: Suggest changing "patients" to "study participants"


comment:
in the audio, the script reads "we" must, should it be you must?


comment:
Apologies in advance if this is a stupid question: The size of the screen is really big - I have to scroll up/down to see the header/progress bar. Is that just my browser setting? Does this meet size specs we have for ncaa?


comment:
How does everyone else feel about the intro? I'm not sure what the client reaction will be, but I think it kicks this course off with a "cool" vibe that alleviates fear that this was gonna be a snoozer. I vote to leave it and see what they think!


comment:
Question: Does this activity impact the meter at all? My first instinct is that I don't think it should, but wanted to confirm.


comment:
Assuming the meter is not affected, let's force the user to re-do this activity until all are correct. (These are critical stats) If any answers are red, it would just reset this screen. Only an "all-green" screen would have the option to continue back to the menu.


comment:
Error: I got the first seven wrong, and when I returned to the menu screen to start 14.8, the diploma was back to center - I'm guessing because it ran out of room?


comment:
Question for the team: Should there be any "Penalty" associated with getting a certain number wrong??? This course is intended to be a reference/resource for learning about the sections of the bylaw, but it feels weird to totally tank and have no consequence...


comment:
...perhaps in lieu of a "penalty" along the way, we could indicate which were answered right/wrong by changing the blue check mark to a green check/red X? Michelle, would that make this menu screen explode? :)


comment:
From the feedback screen, when I click the dropdown "Menu," and then click "menu" within the drop down, it doesn't take me back to the binder screen. If that's a limitation of the storyline menu, let's put a button on the feedback screens so they don't have to mess with the dropdown.


comment:
...or maybe it's broken. Now even when I'm on a different screen, when I click "menu" it takes me back to the fdbk screen.


comment:
Title text should match icon - R&R Strategy Completed (d is missing)


comment:
I'm not sure of the purpose of the red part of the icons.  Is it supposed to show progress?  or what I should click on next?  I find the red highlight and the inconsistent use of the check marks confusing.


comment:
for the R&R Strategy Completed milestone, last sentence, change recommend to recommended.


comment:
1st bullet - the SRR Representative facilitates...


comment:
re: Carrie's 2nd comment - I had the same issue


comment:
Please change the Platform name to be "6800/8800" only.


comment:
In this step we also have 2 Site Mgr: CRAs and Lilly Site Mgr, I think we do need to mention both.


comment:
I think we should move this up to after "What is Informed Consent"


comment:
Per Tera's comment on the process walkthrough, the text should change to:
The milestones contained with the Finalize and Manage Informed Consent Content process are provided below.  

Click on the ICF Decisions Made milestone to begin learning more about the process.


comment:
Per Suzie's comment in the Process Walkthrough Word doc, use CRP/CRS/CP instead of CP.


comment:
Was is Tera's decision to no longer include the Gather & Prepare Trial-Specific Informed Consent process in this course?


comment:
Add a new 1st sentence to cover the decision gateway on whether or not Master ICFs are needed:
When a trial is being conducted at more than one site within a country, master consent documents, including country-level ICFs, addendum ICFs, and assents, may be needed. The master documents help ensure all ICFs created at the site level within the country will meet all country-specific requirements. 
If the Site Manager determines that country-level consent documents are required, follow the Develop Master Informed Consent process.


comment:
Say Trial-level ICF Writer, instead of writer to be consistent with the map


comment:
1st bullet, 1st sentence:
- The Trial-level ICF Writer begins the development of the trial-level ICFs if ICFs are needed at the trial-level, for example if the trial is taking place in more than one country.


comment:
2nd bullet: I would add "as applicable" after Master and/or site-level ICFs are developed, as for example a Master ICF may not be developed for ClinPharm trials


comment:
Audio: add the the last sentence:
"... and is followed when a trial is being conducted at more than one site within a country."


comment:
Agree with Sandy, remove "if a Master ICF was not developed".


comment:
Last bullet say: Site-Level Informed Consent Tracking Log as this is a quality document


comment:
Last bullet, replace "it" by ICF amendments


comment:
1st incorrect feedback: MQO Representative (capital R)


comment:
incorrect feedback: I would just have one and say Not quite. Try again.


comment:
Course number and version are missing:
Course 9156949 
Version 2


comment:
Remove text in footer "Competition Workshop: Blood bank" or replace it with Operation: REVEAL RBSS - Abbott and Grifols


comment:
Actually, just replace by Operation: REVEAL RBSS - Abbott and Grifols


comment:
Roche Blood Safety Solutions, not Bloodbank Safety


comment:
Use exact same characters as from the Consultative selling training


comment:
I don't understand why the button says "Open Files". Could you maybe replace the text with something more straight forward like "Continue"?


comment:
Veinovia Times competitor dossier must absolutely not be available online without protection.
This should link to an internal Roche resource.


comment:
For customer types, please use content from previous training.


comment:
Users should be directed to the consultative selling training and the rbss.roche.com intranet


comment:
Please gray out the text box for the following fields:

LPN Number
PPN Number
Portfolio Domain
Project Code


comment:
the flow of the following 3 screens is awkward.  On this screen (ICF Levels), the last thing said is to look at the different processes, but then we go to Addendum and Assents.  I think that is b/c this terminology is used in the processes, however, without any explanation it feels disjointed.  at the end of this screen or at the beginning of the next one, I would add something like (wordsmith as needed):  Before we explore the processes, let's look at additional documents related to the ICF, that may be created as part of these processes.


comment:
Question for Susie: Since this is the first time we use "CP" in the course, should it be spelled out?


comment:
the first sentence is really long - suggest breaking into two sentences...

Site-level informed consent forms, including Site-level addendum ICFs and assents, are generally required when a trial is being conducted in very few locations and theres no need for a Trial- or Country-level ICF.  Site level-ICFs are also required (confirm that this is required with Susie) when a trial is being conducted at multiple locations with different ERBs and requirements.


comment:
in the "Develop Master and Site Informed Consent course, we took out the text "if a Master ICF was not developed" b/c it implied that this was the only time when a Site-Level ICF would be developed.  Q for Susie - is this the case for Clinpharm too?


comment:
This is a minor change request...each of the milestones begin with "During this milestone..." can we find different ways to introduce the content in each milestone, some examples could be: The key activities in this milestone are... The main focus of this milestone... etc.


comment:
I think the first bullet should be the 2nd sentence in the introductory text for this milestone, not a separate bullet.  Confirm with Susie.


comment:
last bullet, "...how to apply it"?  What is the "it" that is being referred to? Need to be more specific.


comment:
So I did see the "not quite try again" but only when I clicked on the first 1st option.  When I came back and clicked on the 2nd option (1st response) I got the wordier incorrect response.


comment:
I entered values and Pressed Enter to finish but nothing happened


comment:
I might have missed it but I did not see the icon in the training deck


comment:
Seems like the Kind of Disruption option and its abbreviation are both "earlier obsolescence"


comment:
Please change the sentence of "This kind of disruption will cause problems like earlier obsolescence" 

To instead say:

"This kind of disruption could potentially cause the assay to become obsolete earlier"

Keep the Kind of Disruption Abbreviation as:
"Earlier Obsolescence"


comment:
Need a better image for this intro page, perhaps the system view with a couple of sets and switchgear etc all linked up


comment:
small test change - bullet 5 ...point in the evolution...


comment:
Is there anyway we can try and make the office feel more like a Cummins building, maybe the colour scheme or similar, do we have any good shots of the new Indy office area that we can use or some artist impressions of the new COB designs that work


comment:
something like the left hand half of this image would possibly work well in the title slide, or something similar


comment:
I don't see the benefit of the hover over the i to bring up a small pop up then a click to expand. the middle hover doesn't add anything to the experience


comment:
wasn't able to deselect the first answer when I tried to bu the others you can


comment:
Like this but would be good if perhaps there was an image behind the text to emphasise the item, rather than just text on a white box


comment:
sorry, same comment as before with the two step reveal. seems like an extra step for no gain


comment:
I know these are placeholder images but they seem lost on the page and the layout of the images doesn't add much to a new viewer who doesn't understand that the three items all link through the controller.


comment:
I believe the Genset controller is possibly the sum of all parts, think the centre item should have another name that better identifies it.


comment:
nice activity, may be good if once complete the images came together on a genset as the control. Failing that it could at least grow to fill the available space


comment:
this conversation has speech from Penny but no speech from colleague just the big white box, surely he needs to speak as well


comment:
Like this exercise, one question though, is there a similar resource to flashcards for those from the digital age - eg electronic post it's or similar that people may relate to better?


comment:
Who is Penny talking to? is she talking to me the learner or to herself. In some sections she asks a colleague for help but there seems to be something missing, maybe its the manager working on her development plan and Paralleling is something she needs to add to her skillset and these topics are things the manager sets Penny to learn, then Penny can feedback to the manger whilst relating it to the hospital project.


comment:
Is there anyway we can make this intro pic have any ref to Marine, eg a vessel in the background or similar.


comment:
Jacques looks a little to excited in this screen


comment:
Per your comment we need the right icons, I believe there are stock cummins icons for these benefits


comment:
Would be good to not only do the comparison but explain why it is important. Also should place a date at which point the data was correct


comment:
This 95 looks a lot different to the one at the beginning, I don't remember the grey blocks on top, it needs to match as otherwise you are left asking why is this one different


comment:
Remove the last sentence "No other blood system or virology..." This may not be true at some point.


comment:
Reword to 

"If you consider the varying media types supported by the cobas(R) 6800/8800 Systems,"


comment:
In the question, change varying media types to various sample types (to be consistent with the pop up box for the correct answer)


comment:
add just before the ? (not considering positive and negative controls)


comment:
Pop up for Throat and Rectal swabs 

change "does not accept throat or rectal swabs" to "is not validated for use with throat or rectal swabs"


comment:
Please change "Purple Fever is appearing" to "Purple Fever is spreading"


comment:
Please change "prepare a Business Review" to "prepare a Proposal"


comment:
Please add before the second paragraph the following lines:

The Business Case contains crucial information to fill the SPMT.


comment:
Edit: We dont need the second abbreviation excercise, just leave earlier obsolescence


comment:
Please start the text bubble with the following text:

The Risks Scale "High, Medium, Low" is translated to a numerical scale of "10, 5, 1" respectively for the Tableau Portfolio Dashboards.


comment:
Please replace the left hand button to:

"By skipping the Value Creation tab, your project will be excluded from several Tableau Portfolio Dashboards."


comment:
Please replace the right button to:

"If you skip the Value Creation tab you can always talk through it at the Business Review."


comment:
Why doesn't the voice over say - when the decision has been made to close out a site like the text?


comment:
In the first bullet point under sites closed take out IMPACT.


comment:
There are still two buttons - one for responsible for on=site activity and sponsor level though they don't seem to work any more.  Should they be gone now? Why did we combine the text?


comment:
I think that we can change wording now because the monitoring map is up and they don't call them site managers they call them monitors.  I think we should call the site focused manager a monitor now.


comment:
I think we should say that the monitor and the site managers responsible for sponsor level activities work together.  We can actually separate out the monitor from the site managers (CDCs and the SA).  Should make one a site manager for sponsor level activties and make the other one the monitor.


comment:
We should change this person to the monitor


comment:
The how will we provide ongoing care instructions is not correct.  We don't have to provide ongoing care instructions.  I would change to should ongoing care instructions....


comment:
change decision log master list to study decision log.  That is the name in the TMF


comment:
menu appear with hamburger icon, horizontal box to see assets


comment:
remove triangles, increase title text size, allied sol'ns logo in corner can be removed since it's been on the first screen


comment:
Change text to:
During this training course, I will walk you through the process for completing the business review templates at various stages of a product development cycle in preparation for your business review meeting


comment:
Change to:
As you can see here, the Business Review process involves six phases. It begins with your proposal for a new product proposal and ends when you have launched the product launches (LD). In this course, we'll tackle the phases two at a time.


comment:
Change to:
As an IPM with Roche, I know how important proper preparations are for a successful business review. That the foundation of my summary needs to be based on facts and assumptions are transparent because here accuracy isn't a variable


comment:
I'll guide you through the templates so you can be successful at your future business reviews!


comment:
Change to:
As we speak, a new strain of Purple Fever is spreading around the world, and you must prepare for a business review for the new Purple Fever assay. To begin, let's start by reviewing what information we need to gather from other functions.


comment:
Marketing change to Market Intelligence: Hey, I'm Bill from MI. I provide information on market overview, segmentation, and market opportunity as well as competitive analysis.


comment:
Hi, I'm Rob from Research and Development (R&D), and I am responsible for product concept. I also support resource planning for required skill sets.


comment:
IBLs: Change Commercial Inc. to Commercial, including: Reimbursement, R&D, Manufacturing, and Legal


comment:
Regions: We provide feedback on the sales assumptions and ASPs at DO and the 10 year sales forecast at LD.


comment:
Change to:
It's important to know what information is needed from each function when completing your business case and preparing for your business review presentation. Now it's time to review the order and purpose of the business phases.


comment:
Change LD to:
The final phase of the business review process is the Launch Decision phase. This this time, we are clear on the product developed and it's intended use and now want to answer: Are we ready to launch the product?


comment:
Change to:
Great job! We won't review all of the supporting templates for each phase in great detail; instead we'll focus on those template slides that require more explanation. You will also have an opportunity to practice using these slides.


comment:
Change to:
Knowing what questions to answer early on is what helped you get approval to pursue Purple Fever assay! As you prepare for DG, you will need to continue to refine your case - this includes updating the marketing assessment waterfall slide.  (Delete: The Waterfall slide plays an important role in telling your account story.)


comment:
Change to: 
At Proposal, you know the Total Potential Market by region. Since this is an assay, the values are represented as the number of patients (or donations for blood screening) in millions. If it was an instrument, the values would reflect  the number of tests instead.

You also know the Total Addressed and Competitor Market.  As the project progresses, you need to identify changes in the market that will change the original assumptions.


comment:
Add After EMEA:
First study the waterfall at Proposal, then answer the question correctly for how this new information changes the waterfall at DG.


comment:
On point 3, I think we need to change the reference to "three" key competitors to "two", because the only competitors we're looking at are CAT and MTU, right?


comment:
I don't see the added value of entering the numbers again in the think.cell sheet. Remove


comment:
We need a summary slide like this to show the impact of the changes at DG but the think.cell was confusing. Please just show the changes here and remove that slide.


comment:
Delete slides 3.13, 3.14, 3.15. This is not needed


comment:
For the Time To Results Table, can you put the Number of Tests column first. This will make it easier to read


comment:
In order to fill  out the recipe questions for scenario 1, the trainee would also need the process times for the p 480. We had this resource for CT/NG & HPV launch and could leverage it but the information for SurePath should be removed since its only used for HPV.

We would need to specify in the scenario that the samples are urine and swab sample (i.e. not PreservCyt/ThinPrep) since the p 480 resource has process times for various specimen types.


comment:
to my last point, change to

The lab needs to process 200 samples collected in cobas(R) PCR Media for CT/NG


comment:
Change pop-up to
and hands-on time of ~33 minutes (including 3 minutes for cobas p 480 plus 30 minutes for cobas(R) 6800 System)


comment:
Remove "Assume all 85 samples are processed during the same run" from pop-up. This should actually be in the scenario description instead.


comment:
Change to 
The lab needs to process 85 samples collected in cobas(R) PCR Media for CT/NG.


comment:
Scenario 3
Roche to confirm correct answer:

Correct answer is "Load all samples at the same time"


comment:
Number 3 is confusing. Reword to 

CT/NG and TV/MG use _______ Negative Control Kit, however ______ Negative Controls will be required when processing CT/NG and TV/MG during the same run since each assay requires its own set of controls.

First blank "the same"
Second blank "duplicate"
Wrong answers "target specific", "omni NHP"


comment:
The LIS needs to send the _______ to the cobas(R) 6800 System as part of the test order since _______ and meatal swab samples require a different processing volume than _______ and PreservCyt samples.

Blank 1: Sample type
Blank 2: Urine
Blank 3: Vaginal Swab
Wrong Answer: Urethral Swab
Wrong Answer: SurePath


comment:
A woven swab is used to collect a vaginal swab or meatal swab sample...


comment:
for woven and flocked swab, combine into 1 question. Change wording to

What are the hands-on tasks required for swab specimens collected and transported in cobas PCR Media?
(Decap the sample)


comment:
Resources can include those that are also displayed in the recipe book plus one other:

Claims vs competition
Processing time chart for c6800 and c8800 system
p 480 and manual processing time for pre-analytics
TV/MG assay design - I will send you a file for this.


comment:
Trichomonas vaginalis and Mycoplasma genitalium should both be italicized when spelled out.


comment:
Change to 
Rhonda noticed a change to vaginal discharge but feels...


comment:
add to correct answer:

STIs can cause complications during pregnancy so Rhonda should be even more concerned.


comment:
Reword the Not a good question pop up to make less wordy
(While we offer HSV 1 & 2 on the cobas(R) 4800 System)
Capitalize Omni Utility Channel


comment:
All infection types should be italicized throughput training (e.g. M. hominis, Mycoplasma genitalium, Ureaplasma...)


comment:
Correct branding (add "s" to Systems)

Change justified to justify


comment:
Change e.g. TV to e.g. HSV 1 & 2

(this must be a carryover from CT/NG)


comment:
It looks like the feedback I provided during Alpha for the pop-ups got mixed up.

So the feedback after "Good Question" is actually the updated language for the "not so good question" based on my feedback from Alpha. If you use this updated feedback, you can ignore my last comment.


comment:
The Good Question pop-up needs corrected feedback. Can you leverage the same language we used for CT/NG for this scenario?


comment:
Pop-up language for correct statement reads oddly.

Just end the sentence after cobas(R) TV/MG (remove to avoid self-validating...)

(keep the note in parentheses with asterix)


comment:
For the correct answer, reword

"the lab can just load reagent cassettes as needed"


comment:
Pierceable cap pop up

change the last part of the last sentence to "volumes are low, the lab might perceive pierceable caps as an advantage"


comment:
change i.g. to i.e. in the parentheses for pop-up in Decent Question


comment:
For Great Start pop-up 
change last sentence slightly to read

significantly versus their current solution using m2000 for CT/NG plus home brew tests for TV and MG.


comment:
Not sure why Hologic has been changed to Grifols?


comment:
BD Max throughput is 96 tests in an 8 hour shift


comment:
Cepheid

Change to "It depends on the size of the system. One GeneXpert Module processes ~ 5 TV results per 8 hour shift" Sorry, no IVD Test for MG!


comment:
For Hologic

"We believe we have the best performing TV test for female patients since we are RNA-based and were first to market..."


comment:
Hologic logo and name in text seems to be changed to Grifols in multiple places


comment:
Patrice will need to provide the links for the resources section This will include

TV and MG Disease Overview
cobas(R) TV/MG Overview
Competitor Overviews - Hologic, BD, Cepheid, Abbott


comment:
2nd bullet: spell out ERB as it's the 1st use in the course I believe: Ethics Review Boards (ERBs).


comment:
5th bullet: last part of the sentence: should say study participants instead of participants I believe


comment:
Depending on what we decide for the Roles and Responsiblities screen, the second answer option may need to change to "Site Monitor".


comment:
Same comment, may need to change to Site Monitor


comment:
the sentence in the bullet for the milestone is really long and hard to read. any way to break it up?


comment:
remove comma in the second sentence of Mark's first speech bubble


comment:
is the body text the right color here? It looks like it's the same color as the directions


comment:
2nd paragraph - extra space between first and second sentence


comment:
answer choices - is Impact supposed to be all caps? I think it was earlier in the course


comment:
the answer choices "Sales and Marketing..." is not parallel with the other choices


comment:
ok, I'm drawing a line on the capitalization here. I'd remove the caps for study participant and clinical trial here since we haven't capitalized them globally


comment:
This is being picky.... could you make the text not as wide so the word "on" isn't hovering over her hand? THANK YOU!


comment:
Replace icon with one without the red. I believe Matt sent them yesterday. Also, add a checkmark after the user clicks the milestone. See Matt's example.


comment:
Per Sandy's request to remove audio and text about the process start and end, let's change the opening text and audio to "The Recruit Study Participants and Manage Enrollment process involves partnering with the sites to recruit, consent and retain study participants and manage enrollment throughout the trial." I took that directly from the process map so hopefully they will be good with it.


comment:
Let's send Sara's and Mark's suggestions to Sandy and Sophie for confirmation. I'd just send the word document and reference page 2.


comment:
Replace icon that doesn't have red in it and add checkmark.


comment:
Per edits in word process map doc - change the world "aliging" to "managing" in first bullet.


comment:
COMPLIMENT ALERT: You did an awesome job of capitalizing all the roles!


comment:
Remove all drop shadows from cutout people.


comment:
Opening line "During this milestone.." remove the "last" before "visit"


comment:
Agree with Beth. Also remove drop shadow


comment:
Did we get the updated resources we need? If we need more information we can add it to the note to Sandy and Sophie.


comment:
Remove the "How much will it cost to produce" slide. This no longer makes sense as we are not doing the drag-drop of the COGS


comment:
Change to:
To have a successful business review, your data must be consistent and accurate throughout the presentation. For example, the ASP slide at DI/DO should contain the same elements as noted in the customer requirements and main player differentiation slides.


comment:
Delete: Remember that, depending on what part of the business you are in, your total market will be made up of different components. 
Move: If you need a refresher on the different market definitions, click the Help icon. Slide 3.5


comment:
Change to:
Knowing the questions a slide answers helps to understand the message it should convey. Take a moment not to identify the critical question(s) that the Competitive Pricing slide answers.


comment:
Change to:
The Competitive Pricing slide represents the ASP competitive landscape for RMD products and the competition. Now it's your turn to plot your ASP for Purple Fever assay.


comment:
Change to:
Great work! You've used your customer requirements and main player differentiation data to visually support where your product, Purple Fever, is in relation to the competition.


comment:
Change to:
Now let's look at how to determine the COGS Margin for your assay.


comment:
Replace "Pass" for "Approval":

Change the paragraph to say:

Congrats! Your project has been approved to proceed. Prior to the next Business Review you will need to change the Project Phase and update the OnePager data.

Remember, to complete a OnePager for a Business Review the requirements are:

-To have an updated Business Case aligned with Finance.
-The OnePager must match the data presented at the Business Review.


comment:
Please change the Learning Agent dialog to:

Next time you have to update your OnePager, you will need to follow the instructions corresponding to one of the following scenarios.


comment:
Transcript information should be more prominently displayed. Maybe highlight icon and put in a separate line


comment:
Please add the following text in the Learning Agent dialog:

"Click the + New Project button to begin creating a new OnePager!"

Plz make bold "+ New Project button"


comment:
I will provide you with the images and landmark point locations for each item.


comment:
Could we have a scanner (ie barcode kind of scanner) instead of the "electromagnifier" ? This would fit better with the bloodbank theme


comment:
Please change the Learning Agent to say the following:

"It's time to fill in all the information required for your new project. Notice that when you create a new OnePager the Project Phase will begin at "Proposal" by default"


comment:
Please add the following to the Learning Agent dialog:

"To find more information about each of these fields click the Help Icon (insert icon pic)"


comment:
The associate should be offering to provide insights about their current pain points so the Roche rep can better understand Veinovia CBB's needs


comment:
Please add to the Learning Agent dialog:

"Great job! Remember, only create one OnePager per project. Once a OnePager has been created, it cannot be deleted!

Click on the Create New Project button to move forward!"

Make "Create New Project button" bold


comment:
Please add the following to the Learning Agent dialog:

"To find the Investment Date, US LD, and CE LD dates, use the Purple Fever Business Case" <+ insert the business case icon>


comment:
Future trainings will not be in Spain.
Could we use a different clue. Related to Veinovia city or to a location in the blood bank or a congress etc...


comment:
Could you tell us more about this video and what it would include ?


comment:
See previous comment. Screen should be independent of training being done in Barcelona or somewhere else (eg. for the other regions).


comment:
Additional resources on competition should be added here as well. Eg. CMP page, page for RMS, etc...


comment:
This is a good slide. 

Please also insert this slide between the slide where you have to click on the Market Attractiveness button and the slide with the Market Attractivness Excercises


comment:
Just to confirm, 
After this slide, please insert the Help Slide that has the other Learning Agent talking about completing the Market Attractiveness section.


comment:
Please change the excersie so that NAM and EMEA have errors on Market Growth, and cut out from the picture the columns for LATAM, APAC and Total.

Zoom in the new version of the Market Attractiveness table so that the numbers and text are bigger. 
I will also send a pic as support.


comment:
Please add the following as part of the Learning Agent dialog:

"Click on the incorrect data on the Market Attractiveness section"

Please make bold "incorrect data"


comment:
Please add the following to the Learning Agent dialog:

"To save your progress and continue, click on the Save Changes button"

Please make bold "Save Changes button"


comment:
Please include the Learning Agent in this slide too.
He should have this excercise instructions as dialog:

"Now lets enter the Protential Disruptor information. 

Review the Business Case data, then drag the correct data about disruptions to the correct cells"


comment:
Please add the following to the Learning Agent dialog:

"Click on the Create New P&L button to start completing the P&L section"

Please make bold "Create New P&L button"


comment:
Please add the Learning Agent to this slide with the following dialog:

"Drag the correct values for ASP and Units Sold to their corresponding year.

Remember to use the Purple Fever Business Case to find this information!" <+insert business case icon here>


comment:
Please add the following to the Learning Agent Dialog:

"Excellent work. We'll enter the sales data for EMEA next. Remember to save your progress!"


comment:
We need to make the numbers and letters bigger, 
For this, we should cut out the years that do not take part of the excercise" 
I will provide a new pic for this section too


comment:
Please make bold "Business Case" in the Learning Agent dialog


comment:
Will provide a new picture for this excercise


comment:
Please add the following at the end of the Learning Agent dialog:

"Save your progress to continue"


comment:
I would change of which to manage to from which to manage


comment:
For the first bullet point would say site enrollment commitments


comment:
For the study manager I would say I work with any of the other enrollment managers (as they are enrollment managers themselves)


comment:
I would say:  I work with the site managers working on activating the sites and the other enrollment managers.


comment:
I think the end of the first sentence needs fixed.  It is dangling.


comment:
Tried to click on the upper left double arrows to access the topic menu and I only see up and down arrows.


comment:
Resources page - the link to the guidebook goes to the Select and Manage Sites collab site--check with Sophie to see if this should link directly to guidebook page?


comment:
Possibly recommending distracted driving by thinking about the presentation and not focusing on the driving?


comment:
Easy Access means to a technician/supervisor the Access Levels A,B,C D, R so perhaps we need to elaborate on Easy access to repair facilities  or what exactly you mean.


comment:
Day Friday is excellent, this reinforces what we state in Orientation


comment:
Please replace "Let's look under the Risks tab now" with the following:

"Click on the Risks tab  button to continue."

Please make "Risks tab button" bold.


comment:
Please make the R&D risk to be Medium. 

Also make it more explicit on the text that the R&D Risk is Medium "R&D Risk is relatively Medium..."


comment:
After answering the excercise, please have the Learning Agent dialog to be the following:

"The Risks Scale "High, Medium, Low" is translated to a numerical scale of "10, 5, 1" respectively for the Tableau Portfolio Dashboards. As you can see, the risks for the Purple Fever assay give a total risk score of 8."


comment:
Please add the following to the last dialog of the Learning Agent:

"Click Save Changes to save the risks for Purple Fever and continue to the next section"

Please make "Save Changes" bold


comment:
Please change the order of the slides so that this question comes after completing the Value Creation excercise.


comment:
Please make "Value Creation section" bold


comment:
Please add another line on the Finance Business Case textbox for the following:

Investment Date:
6/15/2016


comment:
Letters and numbers are too small, we need to zoom in for this excercise as well. It is ok to cut out the PLR2 and PLR4 columns from the Table. 

We will provide a new picture for this.


comment:
Please add to the Learning Agent dialog the following:

"Use the Save Changes button to save the Value Creation data and continue"


comment:
I agree this is confusing.  I think that the only valid answer is plan for clinical trial production. The last one is part of a map that we call so that is confusing.  Maybe only list the first three options?


comment:
There is a Typo on the NPV with Sunk Costs:
Please replace "2525" with 2025.


comment:
Want to get feedback from SMEs as to if they think that the wording in red is clear.


comment:
In addition, we will also provide word document with the new text with the desired format.


comment:
Please change the Quick Reports on Data text to the following:

"With the SPMT OnePager database the Portfolio Team can select parts of the data to quickly create reports available to our business community for any emerging tasks."


comment:
Please replace "Peer Review" for "Business Review"


comment:
Please correct the "your" typo at the end:

"...any questions you have!"


comment:
Was confused where to click to proceed.
I kept clicking on "Click > to continue" at the right bottom. Then realised it's the > at the top right


comment:
Suggestion - Since the goal of pap or RCCP is not to accurately diagnose Cx Cancer, change title of the scoring from "accurate diagnosis" to "Cx Ca Screening Accuracy" or "Screening Accuracy" The full spelling of Cervical Cancer can be in the mouse-over description.  Other team member suggestions may come-up with a better title.


comment:
change to a  french European names

Change country to France


comment:
Change to Expectations:  Dr Moody does not seem overly interested in changing his current cervical cancer screening method, however he has a few minutes in his busy schedule and agreed to talk with you.


comment:
Change quote, "Why change from the standard of care for Cervical cancer screening?  Pap Cytology works well in my lab and for my OBGYN clients."


comment:
Instructions should be more specific, "Ask only the best questions........"


comment:
I would change the title in:
REVEAL RBSS
AGAINSt 
ABBOTT & Grifols


comment:
Can the transition for first to second tune be changed more gradually


comment:
What does it mean with on board extraction? Aliquoting from the primary tube?


comment:
Details of features and explanation has to be revised


comment:
This part is essential to to consultative selling.
Ask a series of questions to understand the real needs of this customer.
Best questions to ask to identify the need and in which segment this customer is


comment:
Clue symbol is the same as the previous one?


comment:
Resources has to be updated with uploaded documents on basecamp


comment:
I suggest to remove or reword the last sentence. It is too easy to say that a right site selection leads to getting the medicine they need. Many other factors influence that.


comment:
Feasibility is also a very important step in the site selection process. I would add this here.


comment:
double map icon (one purple, one grayed) for #3 milestone button -- R&R Country-specific...


comment:
not sure if i messed up by clicking in and out of the tab, but i think the replay button came up early.


comment:
not sure what happened, but see if the button for the first person at the top extends all the way to end of timeline. it disappeared


comment:
again, maybe im clicking off the screen or something and the slide restarts -- thus messing up the replay triggering. but that and the click next instructions came on early.


comment:
Under Site-Level ICFs, seems like the last sentence "...Site-Level ICFs are developed after the master ICFs are approved." conflicts with the 1st sentence


comment:
respond to stm comment: confirm the sentence is correct


comment:
"The master documents help ensure all ICFs created at the site level within the country will meet all country-specific requirements" sentence is incorrect.  For US, different states may have their own requirements.  Suggest to change to: "The master documents help align the protocol specific language and procedures and within the country-specific requirements."


comment:
Please add CPA as one of the ICF Reviewer.  The CPA role is to review the quality of the draft ICF.


comment:
Suggest to modify the CPA approval to "The CPA approves non-substantive changes to the protocol-specific elements, site information and compensation.  Non-substantive changes is defined as a change not differs from the original meaning."


comment:
Can we have the person as the "Study/Site Manager"?  I think this is consistent with the content in the Reviewer's section


comment:
For the Master ICF Developed section, suggest the following:  "Depending on the study team plan, the Master ICF may be developed by the CPA, Site Manager, or the TPO using the Lilly approved ICF Template."


comment:
suggest the following for bullet #2:  "Confirms that any changes requested by the external parties undergoing ICF Quality Review and Lilly internal approval.  CRP/CP/CRS approves changes related to the risk text.  MQR approves changes related to ICH GCP, Lilly legal text.  CPA approves other non-substantive required text.  I will email you a diagram which CP finds it very helpful.  Is there anyway to include it or create a supplement document for reference?  thank you


comment:
Agree with stm and here is my suggestion:  
Clear communication to the TPO/Site Manager is critical when ICF amendment is required.
- rationale for the ICF amendment
- timeline and responsibilities on regulatory authorities and ERB submission
- sponsor instruction on the timeline and guidance for all current, past, or future study participants


comment:
Can it be consistent on the naming regarding hypens and capitals, i.e. Trial-Level, Country-Level, Site-Level.


comment:
Agree with SV.  Instead of saying "In addition to the ICF,..." Suggest to say, "ICF process includes ICF Addendum and Assent."


comment:
If we use CRP/CRS/CP, then we do not need to spell out.  Thank you


comment:
I wonder if we should make this slide more generic so that this slide can re-used for Clinpharm.  I think we can say the site evaluator works with the appropriate parties to ensure that of the qualified site.  I think calling out trial planner and COM is very late phase focused.  Can we be more generic - is that ok?


comment:
1) suggest to move some of the content from the ICF Finalization section up to the ICF Decisions Made.
2) 1st bullet point:  provide example to explain what "identifies the ICFs necessary the trial means" such as when to develop the Trial-Level ICF, Country-Level ICF, Site-Level ICF.
Trial-Level:  2 countries sharing the same IRB; i.e. US and Canada sites.  Suggest to use TCED if more than 2 countries.
Country-Level/Master ICF: multiple sites within 1 country (i.e. US) use either the Central or the Local IRBs
Site-Level:  single site per country or multiple sites using the same IRB.


comment:
Do not add feasibility as it is not in this map.  It is in Lesli's Schmitz's map.  

Also, I would change order of things the site evaluator does.  I would put follow-up items done at the end.


comment:
It is not clear to me the intent of the ICFs Finalized?


comment:
We can make it clearer that the site evaluator is responsible for these tasks in the identify, evaluate, and select site process.


comment:
Should we take off confidentiality agreements as they may not be stored in TF in the near future?  I think so


comment:
This slide is helpful in explaining what is the Master ICF.  The ICF process is the same for the Trial-level, the Country-Level, and the Site-Level though.


comment:
The pull down button on the far left to move to different sections doesn't appear to be working


comment:
ICF tracking log is not a required document.  It is the best practice. However, it is important that quality review include the ICF version.


comment:
Should we also say that the business defined site manager provides site selection updates to the study team?  That is a new step in the process that maybe we want to highlight?


comment:
I'm turned off by the term "Pap cytology is a flawed, 70-year old standard of care.  Too many women's lives were saved by this technology to call it flawed.  Maybe we could re-write to say "Pap cytology has reached the limits of its usefulness...since better, alternative technologies are now readily available, use of this outdated approach poses a threat to women's health"


comment:
I think we need to be clear about where in the screening strategy Pap is, and how it underperforms i.e. for first line screening, lacks sensitivity, for triage in HPV Primary Screening, doesn't stratify disease as well as CINtec PLUS does. I think we're trying to simplify, but first need to acknowledge the different screening scenarios where Pap shows up


comment:
lower right click to continue confusing since active


comment:
circling/ moving pin icons are confusing, like you are waiting for something to load. If motion was desired to indicate where to click (active) then it should be constrained to unlocked customer only?


comment:
Cool idea, maybe this shows content in thumbnail icons with description I am guessing?


comment:
Consider change wording to HPV "reflex" testing on ASC-US (not "triage") since this is standard syntax


comment:
A gynecologist would not "diagnose" patients, more appropriate "I trust my pap results and use HPV testing only when it is needed on positive pap result"


comment:
Nice look. Review specifics for highlighting the 3 underline phrases for accuracy, for example the single word "colposcopy" isn't to my perception very impactful or new information (example: how often do you receive normal colposcopy and biopsy results...). I do like that you have been specific to how many (3) phrases to highlight.


comment:
cool pop up "rats you stole me sale again"


comment:
For bad question "has your lab told you that pap cytology is not the most accurate..." consider adding a note to describe why we should "not ask that question at all" eg. insulted his current protocol. And/ or maybe share a better way to ask this, eg "what are your thoughts on new clinical data where HPV screening may be sensitive front-line, with cytology as part of triage algorithm?"


comment:
consider rephrase question, I was a little confused until I read the answer. You were trying to understand his management algorithm for re-testing women - or- how his screening algorithm varied by age?


comment:
I would consider the 30 and above important information, since women under 30 are being potentially missed. Also, the word colposcopy or colposcopy for biospy as stand alone without qualifying reason eg. HSIL, doesn't make sense as important. The importance is WHEN they colpo, not if. Eg. some send every ASC-US or greater pap to colpo = over treatment.


comment:
Love the good bad questions, maybe in instructions specifically say "be sure to ask only good questions, since bad questions will result in lost sales dollars"


comment:
For pick the product, this is typically HPV front line with Pap reflex aka "primary screen" or with reflex to CINtec PLUS cytology. Rarely would you expect to position have CINtec Plus front line (at least to a gynecologist), but it is an option to discuss. This is because the gynecologist controls the ordering of tests, and often the staining (CINtec PLUS) is performed by the cytotech/ pathologist (eg. Gyn may not even be privy to this option)


comment:
I like the final outcome page - what I would consider is making the number of "accurately diagnosed"(wrong word, eg accurately managed?) women relative to something, such as ___ more women than with pap cytology alone for a reference point. Also, it could read ___ more cases of pre-cancer caught sooner


comment:
Should there be an instruction about the fact that there's a sequence to follow, and completing each customer type unlocks a next one?


comment:
I think Leanne is supposed to be a "pathologist" for her profession


comment:
Replace the middle right question with, "Do you ever lose women to follow-up when repeat pap testing is required?


comment:
After choosing clues, and submitting , can we also include hints to the learner of what they could use in a follow-up sales call?  such as a specific  Brochure or presentation that explains why the Roche product , in this case, CINtec PLUS can help resolve the implication of loosing women to follow-up testing?


comment:
Rephrase the top left question, "How do you manage women who have ASC-US and LSIL Cytology results."  Keep it simple......This is a fact finding question.


comment:
Rephrase the Doc's answer: "It depends on age, but for women 30 and over, we follow-up ASC-US results with a repeat Pap in 6 months to one year, and we recommend colposcopy for women 25 and older with LSIL  results"


comment:
The 2 important clues are:  we follow-up ASC-US results with a repeat Pap in 6 months to one year  and    we recommend colposcopy for women 25 and older with LSIL  results.    Clues,  It depends on age and Women over 30  are not important


comment:
After submitting clues, provide hits to what the Sale rep should consider using in the sales call.......CINtec PLUS brochure thumbnail link and supporting publications and one pager summary (the pub and one page thumbnail links should be overlapping....and when the learner mouses over each a description pops up.    (we can discuss this idea in more detail during the review call)


comment:
Rephrase middle left question,  "How do you address womens cervical cancer screening needs when Pap cytology is known to miss cervical disease"


comment:
Provide hint here or a "teaching moment"  on how to better ask such a question........a link to "our Story" module where this is addressed.....(We can discuss more on the call)


comment:
Rephrase the Doc's answer to:  "That happens all the time, but we always recommend colposcopy for these women to make sure we they do not have underlying precancerous disease."


comment:
Ignore last Rephrase -  USE this one instead, "It is common.  We always recommend colposcopy for these women to make sure we they do not have underlying precancerous disease.  It often seems like there are a number of negative biopsies on these women."


comment:
Good clues to highlight:  "We always recommend colposcopy for these women to make sure we they do not have underlying precancerous disease. and  "It often seems like there are a number of negative biopsies with these women."     For a bad clue, Please add back in .......We've always done it that way" into the doc's response


comment:
Rephrase top right question, "How often do you receive negative biopsy results from women who had an ASC-US or LSIL pap result"


comment:
Rephrase lower right question: "How do your clinicians deal with the fact that Pap Cytology is an inaccurate test? "


comment:
Replace doc's negative response, "We have been using pap cytology for a very long time, and it works for my clinicians....you are wasting my time, I have patients to see.  Good Day!"


comment:
Similar hint, "Learning moment"  used for the other bad question, link out to "our Story" content, where we approach the weaknesses of pap cytology in a tactful way with the doc.


comment:
After submitting clues, provide hints to the publications and brochures to use in a follow-up call.......CINtec PLUS brochure thumbnail link, associates Publication and onePager Summary thumbnail links, with brief mouse-over explanations.  (I can explain more on our review call)


comment:
Rephrase lower left question:  "How does HPV reflex testing work for you in your lab?"


comment:
Replace the doc's answer with, "It seems to work well for women with ASC-US cytology results, and helps identify women with underlying CIN3 disease.  However, many HPV+ women with ASC-US cytology results often have negative biopsy results.


comment:
good Clue= However, many HPV+ women with ASC-US cytology results often have negative biopsy results.

Bad clue (not a good clue) = It seems to work well for women with ASC-US cytology results


comment:
After submitting clue (same suggestion for the other good questions)  -  provide hints for the learner of the CINtec PLUS brochures and Publications to use in the next sales call.  

Provide thumbnail links to the CINtec PLUS Brochure and associated Publications/one page summary thumbnail links.


comment:
Replace the 3 descriptions with:

Because this product is used as a TRIAGE test for cervical cancer screening.

Because this product can be used as a PRIMARY cervical cancer screening test.  

Because this product can be used with H & E staining to DIAGNOSE cervical disease.


comment:
Replace the txt on the right in green with -  "Thats right, CINtec PLUS Cytology will enhances the performance of pap cytology for Dr Moody by more accurately triaging women who would benefit most with colposcopy, thus limiting over treatment of women who do not need colposcopy."


comment:
This screen should be titled,"Follow-up sales call preparation"


comment:
Re-word, "Select the tools you wish to use...." TO "Select the tools and marketing materials that you will use in your next sales call with Dr Moody (or whoever   Will provide you with a list of correct Publications for each sales call / customer.


comment:
Wentzensen 2012 study with one-pager summary, Schmidt EEMAPS 2011 Study with one-pager summary, Bergeron 2015 Study with one-pager and the incorrect publications (as I asked in previous answer fields, have these studies associated with the cooresponding one-page summary with a mouse-over description.  The learner can still choose the correct publications to reference and use in the sales call......also include the CINtec PLUS Brochure and CINtec PLUS ppt presentation (currently being developed)   This is a global edit for how this screen is being re-formatted.


comment:
"You should use the CINtec PLUS Cytology brochure and PPT presentation, and data references from the Wentzensen 2012 Study, Bergeron PALMS 2015 study, Schmidt EMMAPS 2011 Study in the sales call. Now choose the right positioning......."  This is a global edit relative to the format for the other sales call scenarios


comment:
Replace the middle positioning statement with, "The CINtec® PLUS Cytology test improves the performance of the pap cytology screening.  It empowers pathologists and clinicians to resolve ASC-US and LSIL cytology results, so they can be certain they are recommending follow-up or intervention only for those patients who would benefit.  How about we schedule an evaluation in your laboratory to test your ASC-US / LSIL samples?


comment:
Not sure if Ms. Diagnosis is working as is........maybe we can associate Ms Diagnosis as a competitor sales rep...... Maybe in this screen, the learner is prompted to provide a competitive vendor from a drop down list, or default if no choice is made for a competitor........This way, the learner is competing with another sales rep in the game, named Ms Diagnosis.  The messaging around Ms Diagnosis can change accordingly, like "she is a competitor rep from company X trying to prevent you from growing your business with products from the Roche Cervical Cancer Portfolio."    This is just a suggestion at this point but I think it should work, so we can keep Ms Diagnosis in proper context.....we should discuss this on the review call.


comment:
to a country using co-testing besides the US........will consider Thailand, or Germany, but need to validate with my colleagues in Pleasanton, please advise. 
    
Remember, this learning module is not intended for the US affiliates at this time.


comment:
One of the good questions, "How do you manage women who have NILM Cytology but HPV Positive results?  

In the next screen, The reply would be, "This does happen, and it is a concern, especially with women who are 30 yrs and older. We have to closely follow these women to be sure they are not harboring cervical disease."  In this same screen (the answer screen), hint to the resources that can be referenced to show the disease that can be found in women with Negative (NILM) pap cytology and HPV + results,  using The Wright 2011 pub and Pub alert (associates), CINtec PLUS Cytology brochure, and CINtec PLUS Be Certain brochure , RCCP story deck PPT.  In addition, need to include the appropriate cobas HPV brochures for cotesting (if they exist), (need to ask Pleasantan colleagues )


comment:
OK question -  "Do you ever lose women to follow-up when repeat  co-testing is required due to NILM/HPV+ results? 

The response in the next screen from the Doc,"Unfortunately yes.   We try and tell our patients the importance of returning for follow-up co-testing testing but sometimes it does not happen.  It can pose real problems, especially if they have underlying disease that was not picked-up from their previous pap.   In this same screen (the answer screen), hint to the resources that can be referenced to show the disease that can be found in women with Negative (NILM) pap cytology and HPV + results, using The Wright 2011 pub and Pub alert (associates), CINtec PLUS Cytology brochure, and CINtec PLUS Be Certain brochure , RCCP story deck PPT. In addition, need to include the appropriate cobas HPV brochures for cotesting (if they exist), (need to ask Pleasantan colleagues )


comment:
Suggestion for this customer, next to "Test method", "Changing to an HPV test for Primary screening"

for "Customer quote",  "our national screening program is changing to Primary HPV screening, and I am looking for the best test, for my lab, and to satisfy the clinicians I serve."


comment:
Good question - "How will your clinicians manage women who test positive for High Risk HPV"  

In the next screen, the Molecular Biologist can say, "based on the literature, we expect between 7 - 10% of our population will test positive and will probably follow the ASCCP guideline for using Pap Cytology triage."

After choosing and submitting clues, provide a hint to the literature and brochures Including CINtec PLUS Cytology Brochure, Wright ATHENA PLUS 2017 with one page summary associates.   [this opens up the conversation to including CINTec PLUS as a more sensitive triage option in the product choice and positioning screens]


comment:
Agree -  Leanne needs to be a Pathologist -  and from Germany or Belgium -


comment:
Sorry.......Pathologist not from China, make him from Mexico or Brazil


comment:
for Test Method,  Using an RUO p16 clone for cervical biopsies


comment:
for Test method, "using H&E staining only for cervical biopsies"


comment:
Typo wasn't corrected in 1st sentence upper left corner of screen:
Typo in 1st sentence: ... data is of high quality.


comment:
Process map name should be in dark purple box, low left corner


comment:
should title be Develop? Not Developing?


comment:
line four of text - site level informed consent should be site-level ICF per edits line 3.


comment:
master ICF developed popup- can you insert paragraph break before "if eConsent..."


comment:
I don't think this edit got fully addressed "The Study Manager distributes the Notification of Approved Records.......for trials with 2 or more countries." It looks like no one put in the "for trials with 2 or more countries."


comment:
second paragraph "It" needs to be capitalized at the start of the sentence.


comment:
Need to update the first paragraph (At Trial Level) to match line 44 "For trials with 2 or more countries participating, the Study Manager will distribute.... At the end of that sentence add: For trials with 1 country, the Study Manager can communicate via email."


comment:
I see the problem here - the purple Click here to continue is above the submit button. If you click the purple button, you return without actually answering the question. I think the deal should be that you have to click submit, then the Click here to continue appears with the feedback.


comment:
The header says identify, evaluate and select sites- I recall when we developed the other modules we added qualify in that list since qualify is the red step not select?


comment:
should the 2nd box say site evaluated and qualified as per my first comment regarding the header?


comment:
when I click on the upper left corner to access the different sections of the module nothing appears like in prior modules


comment:
to LAL's comment I think we should since Peter has confirmed that Trialforce should not be used as a repository unless something has changed in the past week we aren't aware of?  I will email Peter and Di to confirm


comment:
should we say qualify and select in the red box or are we ok with just select- I bring this up because the qualify step is the red step not the select step and the qualify step is what indicates the site is appropriate for the trial not necessarily the select step.


comment:
-In the elevator scene allow more time to read and process Mission and Values. Also the text section on Legendary Service. 
- The text in the portion of the video talking with Max about the COS function is crooked relative to the white box and TV.


comment:
No lines connecting warranty and service information


comment:
Should this be titled a Resume? Maybe a GPP or job description, etc.


comment:
On the "how do you interact" slides the guy on the headset has a hand that goes outside the bubble.


comment:
After the answers are correct "warranty" switched to "claims MGMT" Should stay consistent


comment:
Although the text in the GPS device is level it is not the correct orientation to the GPS screen.


comment:
Text overlap with co-worker and click next


comment:
Please remove the branching screen from dropdown menu.


comment:
Change third button title to "Common Changes" instead of "Different"


comment:
In the popup for the branching screen, capitalize the first Agree. Put a comma after button in the first sentence. Add the word "have" between "you" and "completed" in first sentence.


comment:
Change the introduction on-screen text to "Below are the names of the milestones within the process, which refer to the same milestones represented in the Blueworks Live process map." This was a change Sandy made recently and applies to all courses. Thank you!


comment:
First line, it looks like there is an extra space between "Clinical" and "Trial"


comment:
The revised button came on when I replayed the animation.


comment:
For some reason when you click previous in the course the revise screen button appears


comment:
COMPLIMENT ALERT: Your courses have been really clean! Good job!


comment:
Make the calendar book match the next page;
Change Monday to "Welcome to Cummins";
Chance Friday to "Career Development"
Add Saturday "Write Your Story"


comment:
Friday - "Explore the....opportunities within the Service function."


comment:
Under "Welcome Video", the order should be vision, mission, values, and Cummins Operating System.


comment:
1. Second DP comment; change to "arriving at the gym, in the parking lot...."
2. Add Mission in there as well;


comment:
Change Tuesday to "Service Function Basics"


comment:
1. Under each sub-function, use "Roles" instead of "Members";
2. Under Service Capability, remove "Channel Readiness Manager" in roles; 
3. Change to "Service Diagnostics"; the last sentence should be "accurately and quickly leading to a successful repair".
4. Needs to be "Service Technical Training";
5. Under Warranty, "administers, maintains, and improves claim processes to ensure claims are reimbursed fairly and accurately while providing support to our global service provider channel."
6. Service Support - "delivers globally connected service support to our customers by answering inquiries quickly and providing solutions."
7. Service Operations - will provide.


comment:
Take out "you would like" before regarding the Service function.


comment:
The background picture should be a shop environment.


comment:
Third question, use "Key responsibility" instead of "Resume" as the title.


comment:
Make sure the answer keys are matching the previous change.


comment:
Second RM comment - need to change back to Warranty


comment:
Second RM comment;
Title instruction - "Now that you have an idea of how you fit into the Service function, take some time to reflect as you are getting to go to the store."


comment:
Match the sub function titles with the change.


comment:
Confidenciality agreement should be obtain since the first feasibility process, when information is provided to investigators/sites (country validation or Robust, depending if we sent dafts, questionnaires, etc).


comment:
Fix menu icons - move them over slightly to the right.


comment:
Capitalize "Next" in the directional text.


comment:
Feedback from Sandy from other course with branching came in today, please remove everything after the comma in the directions = "then click the Next...".  Please change the congratulation text to "You have reviewed the changes that are required for the completion of this course. Click the Exit button to exit the course, review any associated supplemental material when applicable, then click on the electronic acknowledgment to receive credit."


comment:
Please update menu to reflect slide name change.


comment:
Please take out feedback provide button when you republish


comment:
I realize in the screenshot from Lilly multimedia is one word but I made an edit to that after they sent this... so please change "multimedia" to multi-media"


comment:
Global - Every instance of "Trial-level ICFs" or "Site-level ICFs" or "Master ICFs" please change the first letter to capitalize. This goes for any ICF names. Thank you!


comment:
Make "country" and "site" capitalized in the opening text. Also, change "country-level" to "Country-level" in the direction text.


comment:
update Module header for this module to capitalize according to Leo's edit


comment:
change to "...around Country-level ICFs" in second para


comment:
make sure all of these checkmark screens reset to initial state


comment:
incorrect feedback - needs to say "re-consented at their next scheduled visit."


comment:
Add "required tool" after Notification of Approved Records


comment:
Global - Add "required tool" after Notification of Approved Records in all instances.


comment:
Bullet 4 in transcript change "might" to "may" to match audio.
Bullet 5 in transcript doesn't match audio. Adjust to match audio.


comment:
In Develop Master Informed Consent, add comma after "guidance" in second sentence.


comment:
The back arrow doesn't take you through the pieces of the conversation, it just jumps you to the beginning opening paragraph.


comment:
Please replace with..."the tests that provide the best cervical screening and disease detection for women, and prevent Ms. Diagnosis from spreading....


comment:
In second answer, there is an extra space after "However"


comment:
accurate screening and disease detection


comment:
Add comma after "Negotiation Guidance Document" in the incorrect feedback popup. GLOBAL - Check that you are using oxford comma when appropriate.


comment:
Add comma after "non-Lilly risk information" in incorrect popup


comment:
The last two buttons didn't glow when activated.


comment:
Extra space before "However," in folder text.


comment:
BLP - US market is not the target for this learning experience.

Along with France, I'd like to see China and/or Thailand represented.  Thai or Chinese names as well as customer images.  Let's do away with the white American male for this experience.


comment:
replace "consistency of our products" with "the ability for our products to eliminate subjectivity and interpretation errors which causes disease to be missed by Pap cytology."


comment:
So I didn't select the right underlined words and was penalized.  If I don't, as product manager, how will a trainee learn from this?  In the red box that says "Incorrect.  Not quite."...we've got to tell them that a better answer might be such and so and provide the reason why for them to learn.


comment:
In the "New Version" text, it looks like there is an extra space before "Researchers" before the third line.


comment:
I'm not clear once again here.  Is "we've always done it that way" the answer you are going for BLP?  We need to tell the learner what they should have selected and why when they don't select the right underlined text.


comment:
GLOBAL - Check direction text color. It's the wrong color on this page and I think several others.


comment:
I love Ms. Diagnosis appearing and laughing at me that she has stolen another sale away from me.


comment:
A test doesn't accurately diagnose.  A human does by their interpretation of a test result.  Replace "And you have accurately diagnosed" with...Roche product(s) have helped women get an accurate test result and identify transforming HPV disease when it was present


comment:
The tool is spot on.  It works as I would expect.  The pop-ups, colors, etc make it highly interactive which I really like.


comment:
All studies are good.  Replace Good, OK, and Bad study with "Best study for this customer" and "there is a better study here to select for this customer" or something like that.


comment:
replace "anything new is in regulatory guidelines" with "anything new is in treatment guidelines"


comment:
The pop-up "sales x 3" isn't clear.  Am I getting three times my base sales for this response?  What are my base sales then?  I can't think of what to update this with, but this is not clear for me.  How are point values established, and what determines how many you give me for my selected answer?


comment:
When Ms. Diagnosis pops up...let's build upon the responses she says...beyond "rats..foiled again"

Let's have her respond differently each time she comes into view.


comment:
Please make Raul from Brazil, they use cheaper p16 clones in Brazil.


comment:
BLP - overall, very nice job with this tool!  Thank you.


comment:
This poses a threat to women's health by using a diagnostic tool which is not accurate and misses cervical disease.  It causes women to be over-treated and under-treated and is not an efficient use of health care spending when advanced technologies exist which provide better outcomes for women...or something like that.


comment:
The descriptions for each of the sub-functions should start the same way: 
"Key processes for [sub-function name] include..."


comment:
Warranty - the second sentence, say "this sub-function..." instead of "the sub function..."


comment:
1. Change "Technical Training" to "Service Technical Training";
2. Change "Diagnostic" to "Service Diagnostic";
3. In the second bullet, change the hyphen to period and start a new sentence;
4. In the third bullet, last sentence needs to be "A technician can reach out to the Service Support group for troubleshooting assistance."


comment:
Stop 4 - make the textbox smaller to fit the content, too much white space.


comment:
Change the introduction to: "I remember helping a customer named Tom resolve an issue with his crane."


comment:
Change the text to: "We would like to get to the customer sooner. However, all of our other technicians were involved with other repairs."


comment:
1. Spell out JSA - Job Safety Assessment;
2. Change text to:" I arrived to Tom's location at the time promised. I conducted a Job Safety Assessment (JSA) to...Although we did not get to Tom as soon as we would have liked, he appreciated our arriving when we said we would. Using COS practice #10, our branch completed..."
3. Make sure to consistently spell our or keep abbreviations across the course.


comment:
Same as the other reflection scenario, change it to something else other than driving scene, such as a lounge or parking lot.


comment:
1. First bullet, "...20 application segments, such as on highway, marine, mining, etc."


comment:
Second question:
Start with "The Cummins Service Channel is comprised of.." - eliminate the first sentence.


comment:
Fourth question - take out "biggest"; 

Last bullet - "Google, Facebook, Microsoft, Aggreko and others use our power generation systems as primary or secondary power."


comment:
This is pretty nitpicky but the animation starts and it says 11 pages and the animation shows seven pages on screen (the old number). Can we update the animation to make 11 pages?


comment:
1. "The unit came up to speed, then I heard a surge and the unit failed to come online. I followed the troubleshooting steps but could not identify the issue. So I called for support." - highlight Service Information, Service Diagnostics, and Service Operations.

2. After calling Service Support, when the technician talks to the hospital facility manager, the following three boxes should be highlighted: Service Operations, Service Technical Training, and Service Diagnostics.


comment:
Change the last sentence in the question to say "This includes...";

Option 3: Easy access to certified repair location


comment:
Feedback tool doesn't work for process map. Feedback will go here:

Opening text on introduction there is an extra space between "to" and "the". The replay button disappears when you click it. 

Change text to Milestone 1- During this phase, the Training Owner is responsible for finalizing the plan for training. This includes: 
- Discussions and decisions for finalizing the training requirements. 
- Delivery methods and timing of training for the trial for affiliate, TPO (e.g. CRA) and key site personnel roles. 

The Training Owner also will update the plan for training if there is a change in trial design (i.e., protocol amendment), updated non-protocol-specific training, if applicable, or other changes.


comment:
1. capitalize the word "level" in the video


comment:
Under "HOME", the last bullet needs to say: "Each person's path is unique, based on your strengths, interests, and business needs."


comment:
Take out "afternoon" from Friday Reflection


comment:
Take out "Friday afternoon - "; start with "Time to cheer on the team!..."


comment:
Second milestone, please capitalize first word in second bullet.

Third milestone, add a comma after TPO. 

Fourth milestone, add a comma after completed.


comment:
In the Notebook, under next step,
- Identify a couple of follow-up action items from this course to discuss with your manager.
And take out the note lines.

Take out the second question; 

What's included in the course summary to print off? Will decide whether to include this function or not.


comment:
In transcript, please replace dashes before "particularly" and before "is"


comment:
In first sentence, please capitalize "study teams" and "study coordinators"


comment:
Incorrect feedback, please add periods at the end of bullets


comment:
Global - make sure we are either adding periods at the end of bullets or no periods. Just make it consistent.


comment:
The link button is covering part of the word "assigned"


comment:
COMPLIMENT ALERT: This was incredibly clean! Great job!


comment:
May need to re-import the audio - has a weird glitch partially through it.


comment:
Change first answer to "Site Manager(s)" and second answer to "Monitor"


comment:
change last part to "...needed, requiring very little training!"


comment:
Hologic girl still has a Grifols logo on the rollover state


comment:
I can't click on the hologic girl to get a green check


comment:
Same here-can't click on Hologic girl and she still has a Grifols state.


comment:
Shoot. We need the Grifols girl to be a hologic girl in the animation.


comment:
Take out "Reword to" at the beginning. (The dangers of copy/paste!)


comment:
"me and my dream" sounds weird, maybe swap to say "my dream and me"


comment:
previous comment: OR "hear about a dream I had" or something like that


comment:
If I choose the wrong answer, I get to try again, but if I choose another wrong answer, the "try again" word bubble does not change to show me I chose incorrectly again so it almost seems like my mouse is disabled until I click the correct answer


comment:
It says "Correct Statement" but the answer is false


comment:
again says Correct statement when the answer is false


comment:
incorrect feedback: remove the extra space between "the" and "true"


comment:
remove comma after "job"; remove both "that" in second paragraph, add comma after "again"


comment:
make sure legend appears with the graphics. Right now, seems to come in last.


comment:
Reaching our customers - the picture never changes color when I complete mod 2 and return to menu


comment:
can we get clearer logos? I'm thinking these got lifted from my PPT and I know we have them. TT Matt.


comment:
Cintec histology popup randomly disappears


comment:
we have to get rid of the thumbs up image of the doc. She can look surprised or even slightly upset if needed.


comment:
Get rid of page 5 - we only need one "empty" round of the conversation.


comment:
This needs to look more like a lab than a hospital corridor.


comment:
if I go all the way to the end, the feedback disappears.


comment:
Dr. Feng should look more overwhelmed at the end.


comment:
could the sales rep have a piece of paper in his hand?


comment:
the screen where I make a choice disappears. Only the radio buttons remain.


comment:
when I have to make a choice, can we change the doc's pose? She looks really irritated and I don't believe she should. She shouldn't get annoyed until the conversation goes too far.


comment:
Can you center the correct feedback onscreen?


comment:
the first answer choice should say "When we last met, we talked about the growing clinical evidence that supports HPV testing as a more sensitive front-line screening tool. Have you thought any more about how your pathology lab is evolving?"


comment:
can the thought bubble just be an outline instead of blue fill? It feels like a lot all at once.


comment:
Remove the border from the Testing Objectives box


comment:
Edit the second sentence in note to Roche:Is it okay to use the images above from the roche website?


comment:
In options 1 and 3, change the word bacterium to bacteria


comment:
Delete comma after bacterium in the sentence. All instances of "bacterium" are okay in this context.


comment:
Feedback box is different in these questions than it was in first round (was a speech bubble from anna)


comment:
It looks like feedback format varies - let's just be consistent


comment:
Edit Anna's text: There are four steps in the Smarticles process. Do you remember what comes first?


comment:
Add the word "the" to the customer stmt: "...But we need the phenotypic results..."


comment:
Please add a static screen as the very first one in this section with an image of Anna and a whiteboard. Anna's speech bubble says, "Anna reviews the features and benefits of Smarticles technology before talking with customers."


comment:
Please add a static screen before this one with Anna and the picture of the vivoDx. Her speech bubble says, "Anna provides a high-level description of the vivoDx system, which uses Smarticles technology."


comment:
after finishing mod 3, the Click > directions need to have Click > in bold.


comment:
Can you change the Course Certificate to match the image from Matt's Pap Attack? See Congratulations screen: http://bottomlineperformance.com/clients/Ventana/CervicalCancer/PapAttack/DesignProof/story.html


comment:
We need the 4th online course. We also need to label the images and highlight the Our Portfolio course.


comment:
Check the "Complete x of x" pages. For mod 2 it says 5 of 4 and mod 3 says 12 of 11.


comment:
the complete numbers are also all different colors - may want to TT Matt.


comment:
Change text at top of screen "Learners review an introduction to this customer. This customer focuses on first line screening which lacks the sensitivity of the Roche portfolio."


comment:
Change text at top of screen "Learners review an introduction to this customer. This customer focuses on triage in HPV Primary Screening as Pap cytology doesn't stratify disease as well as CINtec PLUS does."


comment:
There needs to be a page 12 that's the conclusion screen. Use programming note from page 24 - Make sure completed customers grey out or otherwise show completion. When they return here, have the learning agent come onscreen with a speech bubble that says: Now that youve had some practice thinking about how to start a conversation on the limitations of Pap cytology, you should be more prepared to work with your customers in the future. Good work! Click > to complete the course.


comment:
also, let's not have a back or next on this screen. it will get too confusing.


comment:
The drop down menu on the left is all out of order. Can we clean that up? (Delete any extra pages)


comment:
This slide seemed a bit wordy.  Also, we have to be sure the answers to the previous questions are provided


comment:
Discussion about dropping this bylaw off the list.  This is just the definitions bylaw.


comment:
Discussion about the number of questions for each bylaw.  Can there be more than one? Like basic format.


comment:
Team feels like at least 4 questions should be in this section.


comment:
Would like about 3 questions in this section


comment:
Can this just be an informational slide instead of q&a?


comment:
need to be consistent globally with Click > to continue.


comment:
yeah please extend to edge. i'm pretty sure i made it able to fit


comment:
please reuse the checkmark from main menu rather than built-in SL one


comment:
popups -- make big rectangle extending out from opposite edges like we do elsewhere (same colors), but have the hover state be active. i also had a suggestion to have the hover include the "Latin America" text (or whatever the label should be) appear on hover -- maybe in the ocean area or overlaying the land area.


comment:
locked out from advancing when popup was open


comment:
leo -- we can discuss the page number counter thing.


comment:
can this be "Click Elsie to begin the conversation..." or something? seems weird to refer to it as an image


comment:
shorten text box so it flows down the left side, move characters to right and make bigger


comment:
i can blow through this conversation because the characters are clickable at all times


comment:
however we do this, the overlapping of text boxes needs to be cleaner. if we can make sure the speech bubbles line up in a rectangle shape, then we can have this popup go over it. that, or i would do a big green gradient overlay layer (assuming this is a layer) like we do in pap attack


comment:
question for SME's - This screen reads, "keep in close touch with all the other Enrollment Managers for this trial..." but on the next few screens refer to communication with Site Managers - does this need to change to align the roles referred to?


comment:
Need a second answer: prepare calibrators and controls during the daily maintenance pipe


comment:
In the image, update e 801 info ">Reagent Probe (make plural-probes) - Alcohol moistened lint free cloth followed by deionized water - length of probes "


comment:
"Question 6" - Change question to three modules


comment:
Remove the following note below the clear sample data objectives -Have examples of the lab's commonly used calibrators and controls. Tell participants to take notes in their checklists.


comment:
The green checkmark does not appear next to data flow in data manager when done with the content


comment:
The new image needs to go below the signs of successful cal for photometric and immuno to replace the one below there now.  The title on the new image should also include "Signs of successful calibration" above Immunoassay


comment:
The ISE cal image should include another bullet point for a total of 5 bullets which says "No Instrument alarms"


comment:
I must have told you the wrong question to remove.  Put back the one you deleted and remove the current #5  "What are pending results? When do they need to be deleted?"
Pending results are test requests with no results. They need to be deleted weekly to keep the Data Manager database cleaned up.


comment:
You can just add "or cobas e 801 to question 8"


comment:
add e801 questions? You can just add "or cobas e 801 to question 8"


comment:
Need to add new image and also add the e 801 issues I have created content for a new 801 case study and will provide to Lori so she and put it in the correct format.


comment:
On point 4, change "shipyard" to "shipyards"


comment:
Change the 5th bullet: "Distinguish the QSK95 Marine from the competition."


comment:
Nice to have: Can you move the statement "Variable speed ratings have flat power band..." closer under the chart to create more space before the word "Ratings". Also, I think it should be in a smaller font and italicized, while the word Ratings should be bold and not italics.


comment:
Add the following above the buttons: 
The QSK95 Marine is covered by a comprehensive warranty that is valid globally, wherever Cummins-authorized service is available. [blue text] Click the buttons to learn more.


comment:
Make sure that the direction text changes to "Click Next to continue" once all of the buttons have been clicked.


comment:
I think that you need to include all of the correct options in the list, especially if you include distractors. So, either remove the distractors and replace them with "Mining" and "Oil and gas" OR add "Mining" and "Oil and gas" as additional correct options. If you decide to leave in the distractors, I think it should be "Irrigation Pump Systems" and "Aircraft" (remove "s" from Pump and Aircraft)


comment:
Could we get rid of the feedback layers on Show What You Know and instead, have it jump directly to this screen? Recommend: 
Change the screen title on this page to: "How Did You Do?"
Change the text to display a variable reference that either says "Great job! You know that the QSK95 has been proven in the following markets." OR "Not quite. The QSK95 has been proven in the following markets." On the Show What You Know screen, set up a text var that populates on this screen based on whether they've picked all the right options or not. Ping me if this makes no sense :-).


comment:
Need to change the screen title to: The QSK95 Marine Markets.


comment:
Change intro text to: The QSK95 Marine supports six marine market segments. [blue text] Click each vessel to learn more.


comment:
The specialty ships don't seem to have a selected state (no glow). Need to add glow around both with either is selected.


comment:
Global for pop ups on this screen: Need to change the first sentence to: 

"Vessel types in this market segment include:"

On Specialty pop up: 
first bullet should be "Dredger" 
third bullet: make "Units" lowercase


comment:
Gov pop up--
Change first sentence to: "Vessel types in this market segment include:" 

Make first bullet plural to match the others (Patrol boats)


comment:
change first sentence: "Vessel types in this market segment include:"


comment:
Change first sentence: "Vessel types in this market segment include:"

Make "boat" plural in first bullet


comment:
Passenger pop: Check for overlapping images or hotspots here, if that's what you're using. I had to click on this image a few times before the right pop up appeared. Kept getting "Offshore". 

Change first sentence to: "Vessel types in this market segment include:"


comment:
Need to add a colon after (AHTS) in second bullet with the following after the colon: Hybrid propulsion (conventional + diesel-electric)


comment:
Add the engine application after patrol boats: DE propulsion or auxiliary-prime power


comment:
Add application type after Dredgers: auxiliary-prime power, DE propulsion, and variable speed propulsion

Check slides 13-14 in source PPT (Marine Course in Screenshots) to make sure that all the ones that have some kind of engine app listed are included)


comment:
Need to change the content in the pop up to match what's in the content worksheet ppt, slide 11. 

Under More Power heading:
The QSK95 Marine provides more power than the high-speed competitors in its class. This means we can offer medium-speed customers a new high-speed engine alternative. The features that enable this benefit are: [bullets instead of commas] Turbocharger System, Gear Train, HP Fuel Pump. 

In the customer talk bubble:
More power means I can do more work than I could before. I get the advantages of a high-speed engine as a medium-speed customer.


comment:
edit text under More Uptime heading:

The QSK95 provides more uptime for our customers using: [bullets instead of commas] A design methodology resulting in long component life, New materials technology for long-life components, A service approach designed to maintain the engine


comment:
Change text: 
The QSK95 engine uses component designs shared by other Cummins engines. This increases service parts availability and enables the use of Cummins unique service tools for increased safety and reduced maintenance time. All critical parts go through extensive serviceability reviews to ensure easy maintenance and service.


comment:
Add a comma after "tank" (It also allows for a smaller fuel tank, which increases...)

I think we need a character that's less formally dressed :-). I'm guessing we're running out of options, but if you can change it, let's do that.


comment:
Hyphenate "medium-speed" and "engine-mounted" (global)

Remove: "The features that enable this benefit include:" and replace with "Engine-mounted components include: [bullets] Lube pump, Sea water pump, Circulation pump, Fuel filtration, Lube filtration


comment:
Next to Hank's picture, under his name, add "Vessel Type: Harbor Tug"


comment:
Change "Heat Shield" to "Modular Heat Shield" and change "Cylinder Block" to "Initial Design". Both should be correct, the others should be incorrect.


comment:
Need to change the feedback to say that the correct features are the Modular Heat Shield and the Initial Design. Change second paragraph in both correct and incorrect feedback to read: The modular heat shield provides easy access and removal. The initial design of the engine allows mechanics to safely and efficiently maintain the engine over its life.


comment:
Make the correct feedback consistent with incorrect feedback. Correct answers should be "Modular heat shield and initial design". Second paragraph should say: The modular heat shield provides easy access and removal. The initial design of the engine allows mechanics to safely and efficiently maintain the engine over its life.


comment:
Add the vessel type back in: Offshore Supply Vessel (for consistency)


comment:
remove third bullet under Notes. Change second bullet to: cost of ownership and vessel utilization (how often they run or not) are important to him


comment:
Change the second paragraph in correct/incorrect feedback to: 
All of these features contribute to Joe's profitability because they ensure his fleet runs efficiently, resulting in lower cost of ownership. Features like long-life components and shared component designs enable easy maintenance and improve uptime, which helps Joe's bottom-line.


comment:
I guess the vessel type would be Government Vessels? 

Notes: 
bullet 1: Needs multiple power options, but has limited space when designing engine rooms
Remove bullet 2


comment:
Feedback (both correct and incorrect): 
Multiple power options in a single engine will help Jackie make the most of her space limitations and simplify installation.


comment:
Make sure that the notes for Jackie are the same. They changed for Q2--refer to previous feedback for the bullets that should appear there.


comment:
Change option three to "More engine-mounted components" and change option five to "Gear Train" and make all options correct.


comment:
Change correct options in first paragraph to: Turbocharger System, HP Fuel Pump, More engine-mounted components, Engine circulation pump, and Gear Train.

Change second paragraph to: These features ensure that Jackie can pack all the power of a high-speed engine into her limited engine room space. They also enable easy installation and more room for mechanics when it's time for maintenance.


comment:
OK, don't kill me, but I think we should go back to the original screen title: Let's Review.

Change text to:
Whether your customers operate tugboats or coal barges, the QSK95 Marine's features provide benefits to meet their needs. Be sure to think about how each of these benefits apply to your customers before you meet with them.

Remove bullets in talk bubble and add the names of each benefit below the appropriate icon (just don't make the icons clickable).


comment:
Just have one CAT logo and one MTU logo with each engine underneath as separate bullets.


comment:
Change the talk bubble text: 
Now that you have learned what makes the QSK95 Marine a good fit for your customers, let's see how it compares to some competitors' engines. (NOTE: I don't think we need Jacques to refer to the resource since there's a note).


comment:
Put a note to Cummins: Information from slide [add the slide number] in source PowerPoint. Need help explaining why a heavier engine is better for customers.


comment:
Change first sentence: The QSK95 Marine and the 3516C have similar HP/liter numbers; both are around 25-26 kW/L. 

Change last sentence: The QSK95 Marine also offers a longer life at the same power level.


comment:
Put in a note to Cummins: Information from source Powerpoint, slide [add slide number]. Why is this important to customers?


comment:
Somewhere on this screen we need a note to Cummins: The resource doc will include more detail about weight/power density/RPM/Package Size/Fuel Economy; the popups in this section provide the key takeaways for each category and each competitive engine vs. QSK95 Marine.


comment:
Should kW/l be kW/L (capital L)? I am not sure, it just looks weird.


comment:
In general on the competitor weight pop-ups, I think we need to add a note asking them to help us understand why it's better that the QSK95 Marine is heavier. My thought is: if it's not a competitive advantage, why include it? (maybe word it in a nicer way, haha)


comment:
change second sentence: The QSK95 Marine's lower power density results in a longer engine life than the MTU 16V 4000 M73.


comment:
Change the second paragraph: The 16V 4000 M73 has more RPM, but the QSK95 Marine offers more usable power and a longer engine life.


comment:
Here's another spot for a note to Cummins. We need help understanding how a larger package size is a competitive advantage here. 

(sorry, can't stop giggling about package size)


comment:
I think you can remove the "True or False" from the talk bubble.

Change "will offer" to "offers" in the T/F statement.


comment:
in the feedback, make sure "will offer" becomes "offers" and "lover" becomes "lower".


comment:
see previous feedback about adding a note to Cummins on the competitor weight pop ups. How is this a competitive advantage for Cummins? If it's not, why include it?


comment:
Change second sentence to match the edit to the power density pop up on the other MTU engine (make them consistent).


comment:
Change second sentence to: The 20V 4000 M73 has more RPM, but the QSK95 Marine offers more usable power and a longer engine life.


comment:
refer to previous comments about asking Cummins why this is important


comment:
check to make sure that the blue directions change to "Click Next" after they've completed all the pop ups.


comment:
I don't think you need the words "Fill in the blank" in the talk bubble. Maybe get a second opinion, but I'd remove it.


comment:
Make sure that the Competitor's name/engine name are in the screen title (none of them should say "Competitor 3" or whatever)


comment:
The tissue images in the "Customers who use other Roche solutions" and "Customers who use competitor digital pathology solutions" are the same. They should be different. If you need more images, I can provide them.


comment:
Roche is moving towards sentence case capitalization. These titles need to be edited to reflect that.


comment:
Same comment: Is it a competitive advantage to be lighter or heavier? We need help here to understand if we have the advantage or not, and if not...how to positiion it.


comment:
The "continue" button does not work for me here.


comment:
Add a note here asking how this is a competitive advantage. It seems like it's not since we said that lower power density was an advantage on other screens.


comment:
Note to Cummins: How should we position this as an advantage?


comment:
see previous comments--need help from Cummins to understand what's ideal here and why


comment:
Make sure that the screen title has the competitor's name, not the placeholder name.


comment:
Make sure directions change to "click next" after all have been selected. It's probably not changing because you added Fuel Economy; guessing that it's changing based on the states and that one isn't added into the trigger since it's new.


comment:
We might want to put a note here asking Cummins to help us understand where the QSK95 Marine has the biggest competitive advantage against the CAT engine. Then, we can write a question about that. (again--comment applies to all Show What You Know questions).


comment:
Change first sentence: 
It's always important to know your competition so that you can highlight the Cummins' advantages that best meet your customers' needs. 

Change second sentence:
Remember to download and save the Resource doc and refer to as you prepare to meet with your customers.


# Modules

moduleName:
Build Your Implantable System for Remodulin Team


moduleName:
Enlist" Duo Herbicide With Colex-D" Technology


moduleName:
Chapter 3: The Human Resources Organization


moduleName:
Chapter 4: Human Resources Functional Excellence


moduleName:
Regulatory Considerations in Design Control


moduleName:
Software & European Conformity Marketing


moduleName:
Weed control and weed resistance management with Enlist Duo


moduleName:
Enlist Duo" herbicide with Colex-D" Technology


moduleName:
Stewardship guidelines for application of Enlist Duo" herbicide


moduleName:
Common Challenges with Grossing and Processing


moduleName:
Market Forces and the Customer Landscape


moduleName:
Transitioning Middleware to Downtime Mode


moduleName:
Admin Only - Adding a Test to Downtime Ordering Configuration


moduleName:
Admin Only - Adding a Profile to Downtime Ordering Configuration


moduleName:
Module 1: Getting Started with Requirements


moduleName:
Module 5: Developing Great Customer & Business Requirements


moduleName:
Scenario 1: Scenario 1: US Fault Code Error


moduleName:
Scenario 2: Scenario 2: QSK60 2MW Commercial Generator Issue


moduleName:
Follow the Sample - Control Unit and cobas Link


moduleName:
Get to Know the Analyzer: What Does it Do?


moduleName:
Get to Know the Analyzer: How Does it Do it?


moduleName:
Explore the Analyzer: Sample Probes, Containers, Controls, and Calibrators


moduleName:
Explore the Analyzer: Racks and Sample Containers Review


moduleName:
Medtronic: Get Ready for RIS - New Section


moduleName:
Module 1: The Develop, Finalize & Deliver Training Process


moduleName:
Lilly NGD: Dev. Site Act. and Enrollment Plans


moduleName:
Lilly NGD: Recruit Study Participants and Manage Enrollment


moduleName:
Module 3: The Protocol-Specific Training Content Design Tool


moduleName:
Scenario 4: Scenario 4: Commercial Marine Situation in Singapore


moduleName:
1A - 24 hour lab with cobas e 601 module(s) only


moduleName:
1B - Non­-24 hour lab with cobas e 601 module(s) only


moduleName:
2A - Non­-24 hour lab with cobas c 501 and cobas e 601 module(s)


moduleName:
2B - Non­-24 hour lab with cobas c 501 module(s) only


moduleName:
3A - 24 hour lab with cobas c 501 and cobas e 601 module(s)


moduleName:
3B - 24 hour lab with cobas c 501 module(s) only


moduleName:
6A - cobas c 501 and cobas e 601 module(s) connected to Pre-Analytics


moduleName:
6B - cobas c 501 module(s) connected to Pre­Analytics


moduleName:
Coach to Identify Where Account Plans are Needed


moduleName:
Module 2: The Value of Effective Training


# Pages

pageName:
12:Your Role: ISO/SC Settlements Analyst


pageName:
5 Introduction to Customer Support Excellence


pageName:
9 How will we achieve Customer Support Excellence?


pageName:
4 What Is the Impact of Customer Support Excellenc


pageName:
11 Applying the standards: physical space


pageName:
9a Applying the standards: written communication i


pageName:
9b Applying the standards: written communication -


pageName:
9c Applying the standards: written communication -


pageName:
9d Applying the standards: written communication -


pageName:
9e Applying the standards: written communication -


pageName:
9f Applying the standards: written communication -


pageName:
9g Applying the standards: written communication -


pageName:
9h Applying the standards: written communication -


pageName:
9i Applying the standards: written communication -


pageName:
9j Applying the standards: written communication -


pageName:
9k Applying the standards: written communication -


pageName:
10a Applying the standards: nonverbal communicatio


pageName:
10b Applying the standards: nonverbal communicatio


pageName:
10c Applying the standards: nonverbal communicatio


pageName:
10d Applying the standards: nonverbal communicatio


pageName:
12 Applying the standards: work deliverables


pageName:
1 What can you do to enable customer success?


pageName:
2.3 What can it do? (distractor 1 incorrect)


pageName:
2.4 Here's what I've learned (Steven's thoughts)


pageName:
09: Activity-Communicating in Transition (screen 1


pageName:
10: Activity-Communicating in Transition (screen 2


pageName:
11: Activity-Communicating in Transition (screen 3


pageName:
6: Activity-Working the Model (screen 1)


pageName:
7: Activity-Working the Model (screen 2)


pageName:
08: Communicating Customer Success Animation


pageName:
01: What Does Coaching Customer Success Look Like?


pageName:
Cummins Recreational Marine Market Share


pageName:
002: Discussion with the PI and Site Staff


pageName:
04 How Source Documentation is Like Taxes


pageName:
6: post video text-clip 1 AM (beta update)


pageName:
6: Decontamination and Infection Control


pageName:
9: Perms, Activators, Neutralizers, etc.


pageName:
3.14 Types of settlements files (bill determinants


pageName:
3.14 Types of settlements files (invoice)


pageName:
3.14 Types of settlements files (settlements state


pageName:
3 - Working Together: Internal and External Recrui


pageName:
4 - Working Together: Hiring Manager and Line HR


pageName:
7: How antibodies are created - cartoon base


pageName:
8: How antibodies are created - cartoon 1


pageName:
9  How antibodies are created - cartoon 2


pageName:
10  How antibodies are created - cartoon 3


pageName:
11  How antibodies are created - cartoon 4


pageName:
12  How antibodies are created - cartoon 5


pageName:
13  How antibodies are created - cartoon 6


pageName:
14  How antibodies are created - cartoon 7


pageName:
15  How antibodies are created - cartoon 8


pageName:
16  How antibodies are created - cartoon 9


pageName:
17  How antibodies are created - cartoon 10


pageName:
4 Direct Fluorescence - 2 attaching to protein


pageName:
5 Direct Fluorescence - 3 visible with microscope


pageName:
11 Indirect Fluorescence - 1 adding label


pageName:
12 Indirect Fluorescence - 2 attaching to antibody


pageName:
15  Direct enzyme detection - 1 adding label


pageName:
16  Direct enzyme detection - 2 attaching to prote


pageName:
17  Direct enzyme detection - 3 chromogen and subs


pageName:
18  Direct enzyme detection - visualize with micro


pageName:
20 Indirect enzyme detection - 1 overview


pageName:
21 Indirect enzyme detection - 2 adding label


pageName:
22 Indirect enzyme detection - 3 chromogen and sub


pageName:
24  Endogenous biotin staining - 1 endogenous stai


pageName:
29 Indirect non-biotin multimer (OptiView) - base


pageName:
30 Indirect non-biotin multimer (OptiView) -  1 mu


pageName:
31 Indirect non-biotin multimer (OptiView) - 2 HQ


pageName:
32 Indirect non-biotin multimer (OptiView) - 3 HRP


pageName:
33 Indirect non-biotin multimer (OptiView) - 4 chr


pageName:
2 Before you begin - 1 no perfect fixative


pageName:
3 Before you begin -  2 no perfect marker


pageName:
6 Before you begin - 5 everything positive


pageName:
9 staining patterns - nuclear and cytoplasmic


pageName:
12 staining patterns - membraneous and golgi


pageName:
15 - Use Your Resources; Other Colleagues


pageName:
08 - Submit a miscellaneous bid component (GHG)


pageName:
09 - Submit a miscellaneous bid component (GHG) (c


pageName:
10 - Entering real-time daily bid components


pageName:
11 - Entering real-time daily bid components (capt


pageName:
13 - Using the real-time bid summary (captivate)


pageName:
04 -  Submitting a self-schedule (captivate)


pageName:
06 - Submitting a supply bid (captivate)


pageName:
07 - Submitting a miscellaneous bid component (GHG


pageName:
08 - Submitting a miscellaneous bid component (GHG


pageName:
09 -  Submitting real-time daily bid components


pageName:
10 -  Submitting real-time daily bid components (c


pageName:
12 - Using the real-time bid summary S1Q1


pageName:
13 - Using the real-time bid summary S1Q2


pageName:
14 - Using the real-time bid summary S2Q1


pageName:
15 - Using the real-time bid summary S2Q2


pageName:
05 - Working in SIBR (simultion 1) (captivate)


pageName:
07 - Working in SIBR (simultion 2) (captivate)


pageName:
09 - Working in SIBR (simulation 3) (captivate)


pageName:
2: What Should Jane Do? (submit iHCP request)


pageName:
2: What Should Jane Do? (purchase the items)


pageName:
5: Answer Julie's questions 1 (incorrect)


pageName:
6: Answer Julie's Questions 2 (notebook)


pageName:
6: Answer Julie's Questions 2 (incorrect)


pageName:
7: Answer Julie's Questions 3 (notebook)


pageName:
7: Answer Julie's Questions 3 (incorrect)


pageName:
6: Your Role: SC bid/base schedule submitter


pageName:
01 Introduction to the Pump and Other Components


pageName:
13 Pump Refill and Longevity Estimation Table


pageName:
2 Prevent a market dispatch (transcript)


pageName:
3 Cycling a resource through its FOR (correct)


pageName:
3 Cycling a resource through its FOR (incorrect)


pageName:
4 Fixed output below desired point (correct)


pageName:
4 Fixed output below desired point (incorrect)


pageName:
4 Derrick's decision (scenario 1 correct)


pageName:
4 Derrick's decision (scenario 1 incorrect)


pageName:
6 Marissa's decision (scenario 2 - correct)


pageName:
6 Marissa's decision (scenario 2 - incorrect)


pageName:
8 Nick's decision (scenario 3 - correct)


pageName:
8 Nick's decision (scenario 3 - incorrect)


pageName:
2 adjusting for a load forecast error (base)


pageName:
2 adjusting for a load forecast error (transcript)


pageName:
2 adjusting for a load forecast error (scenario)


pageName:
4 adjusting for a new N-1 value (transcript)


pageName:
5 Return ACE to pre-disturbance (transcript)


pageName:
2 adjusting for a load forecast error (edwin's tho


pageName:
9 adjust load forecast STUC only (show it 4)


pageName:
05 Reports: All Results (By Location and Instrumen


pageName:
08 QC Summary (By Location and Instrument)


pageName:
09 QC Summary (By Instrument Type and Location)


pageName:
19 Test/Sample Count (By Location and Instrument T


pageName:
28 Generate, Save, and Mark as Favorite Demo


pageName:
2: When do I submit: - RDT startup (base)


pageName:
7: Intro to completing the RDT (transcript)


pageName:
7: Intro to completing the RDT (scenario setup)


pageName:
8: Completing the Resource tab (simulation)


pageName:
2: You try it: Introduction (transcript)


pageName:
5: Uploading the RDT (feedback-incorrect)


pageName:
04 Catheter Complications during Implant


pageName:
9: Completing the Ramprate,Heatrate,and Startup ta


pageName:
10: Completing the Ramprate, Heatrate, and Startup


pageName:
16 - Try It: Load HBV Adj, Cont, Samples


pageName:
17 - Try It: Load HCV Adj, Cont, Samples


pageName:
034: Try It: Load Controls and Calibrators (1)


pageName:
035 -Try It: Load Controls and Calibrators (2)


pageName:
036: Try It: Load Controls and Calibrators (3)


pageName:
2 Why the CTP Communication Protocols Matter


pageName:
10 Correct the Misperception: Question One


pageName:
11 Correct the Misperception: Question Two


pageName:
12 Correct the Misperception: Question 3


pageName:
10 Identify market infeasibility (transcript)


pageName:
13 confirm long-term balance (transcript)


pageName:
14 See it in action summary (transcript)


pageName:
14 See it in action summary (edwin's thoughts)


pageName:
4 first things first (incorrect 1, correct 2)


pageName:
4 first things first (incorrect 2, correct 1)


pageName:
12 confirm long-term balance (transcript)


pageName:
13 You try it summary (edwin's thoughts)


pageName:
3: RDT and its impact on market applications


pageName:
18 - Try It: Handling an Emergency Sample


pageName:
12: Multi Stage Generators - CONFIG RAMP


pageName:
12: Multi Stage Generators - CONFIG_STRT


pageName:
1: Energy Transfer System Resources (menu)


pageName:
3: Energy Transfer System Resource limits


pageName:
6: Energy profiles and transmission profiles


pageName:
3 what can it do (distractor 1 incorrect)


pageName:
3 what can it do (distractor 2 incorrect)


pageName:
7 understanding dynamic tabs (availability)


pageName:
7 understanding dynamic tabs (as availability)


pageName:
7 understanding dynamic tabs (max/min energy)


pageName:
7 understanding dynamic tabs (max/min load)


pageName:
7 understanding dynamic tabs (use limited)


pageName:
11 fixing an inconsistent outage (setup)


pageName:
13 modifying an outage without overlaps (setup)


pageName:
14 modifying an outage without overlaps (sim)


pageName:
15 modifying an outage with overlaps (setup)


pageName:
16 modifying an outage with overlaps (sim)


pageName:
12 modify an outage with overlaps (setup)


pageName:
8 fix an inconsistent outage (transcript)


pageName:
6: Map - Hospital full med facilities (layer)


pageName:
03 Review the Edits: Flyer (correct feedback)


pageName:
03a Review the Edits: Flyer (incorrect feedback)


pageName:
05 Review the Edits: Radio (correct feedback)


pageName:
05a Review the Edits: Radio (incorrect feedback)


pageName:
03 Why Reviewing Site Generated Content Matters


pageName:
07 Review the Edits: Web Banner (correct feedback)


pageName:
07a Review the Edits: Web Banner (incorrect feedba


pageName:
2.05a: Explore the Blueprint Sample Supply


pageName:
2.05d: Explore the Blueprint Reagent Cassette Draw


pageName:
2.05e: Explore the Blueprint Consumable Drawer


pageName:
2.12: Try It: Monday's Reagent Cassettes


pageName:
2.21: Try It: Loading Monday's Samples part 2


pageName:
2.22: Try It: Loading Monday's Samples part 3


pageName:
2.25: Try It: Finish Monday's Testing part 2


pageName:
2.26: Try It: Finish Monday's Testing part 3


pageName:
2.27: Try It: Finish Monday's Testing part 4


pageName:
2.28: Try It: Finish Monday's Testing part 5


pageName:
2.29: Try It: Finish Monday's Testing part 6


pageName:
2.30: Try It: Finish Monday's Testing part 7


pageName:
2.33: Try It: Tuesday's Processing Plates


pageName:
2.53d: An Emergency Sample follow up question


pageName:
2.53e: An Emergency Sample correct answer


pageName:
2.53f: An Emergency Sample incorrect answer


pageName:
2.59: Completing the Field Report cont'd


pageName:
2.60: Question Conqueror: Getting Started


pageName:
3.05a: Explore the Blueprint Plate Carrier popup


pageName:
3.05b Explore the Blueprint tip carrier popup


pageName:
3.05c: Explore the Blueprint stationary popup


pageName:
25- An Emergency Sample follow-up question


pageName:
3.05d: Explore the Blueprint sample popup


pageName:
3.05e: Explore the Blueprint reagent popup


pageName:
3.05f: Explore the Blueprint continue popup


pageName:
3.05g: Explore the Blueprint plate loading drawer


pageName:
04 The Reviewing Site Generated Content Process


pageName:
07 Content Reviewed, Finalize, and Distributed


pageName:
03 Recruitment and Retention Review Guide


pageName:
7a: No sourcing or sinking? (Sonee layer)


pageName:
7b: No sourcing or sinking? (Ariel layer)


pageName:
2 Your Role: PAH and Implanting Physician


pageName:
3.4 FMM Scheduling Point/Tie Combo LMP (2)


pageName:
3.4 Scheduling Constraint Shadow Prices (3)


pageName:
3.4 MPM Intertie Constraint Shadow Prices  (5)


pageName:
3.4 MPM Intertie Constraint Competitive Paths (6)


pageName:
3.6 System Load and Resource Schedules (1)


pageName:
3.6 Flexible Ramp Surplus Demand Curves (9)


pageName:
3.6 Uncertainty Movement by Category (10)


pageName:
4 The Budget and Contract Development Process


pageName:
08 Knowledge Check: Clinical Trial Materials


pageName:
10 Knowledge Check: Patient Reimbursement


pageName:
03 Review the Exception Request - Site One


pageName:
05 Review the Exception Request - Site Two


pageName:
16 Additional Information: Exception Three


pageName:
08 Review the Exception Request - Site Three


pageName:
12 Explain Your Reasoning: Exception One


pageName:
14 Explain Your Reasoning: Exception Two


pageName:
15 Maximizing Approvals: Exception Three


pageName:
01 Identify, Evaluate, and Select Sites Process


pageName:
02 Preparation for Site Evaluation Completed


pageName:
03 Identify, Evaluate, and Select Sites Process


pageName:
06 Judgement-Based Decision Making - Introduction


pageName:
08 Judgement-Based Decision Making Cont'd


pageName:
Validate outages going to the market intro


pageName:
Validate outages going to the market sim


pageName:
Operate outside standard market timelines intro


pageName:
Operate outside standard market timelines sim


pageName:
Operate outside standard market timelines


pageName:
Operate outside standard market timelines Q2


pageName:
Identifying and correcting topology errors intro


pageName:
Identifying and correcting topology errors sim


pageName:
03: Getting started with AIM (base layer)


pageName:
05:  Create a user and grant access (intro)


pageName:
06:  Create a user and grant access (Captivate)


pageName:
09:  Request and manage endorsed users (Intro)


pageName:
10:  Request and manage endorsed users (Captivate)


pageName:
12: Manage ACL groups (layer 1 - ACLform)


pageName:
12: Manage ACL groups (layer 2 - AddAsset)


pageName:
12: Manage ACL groups (layer 3 - ViewAsset)


pageName:
13: Manage email notifications (base layer)


pageName:
3: Create and manage user access (intro)


pageName:
4: Create and manage user access (Captivate)


pageName:
7: Request and manage endorsed users (Intro)


pageName:
8: Request and manage endorsed users (Captivate)


pageName:
003B: Trial Level Informed Consent Created


pageName:
3.5 Sufficiency Evaluation Demand Forecast (4)


pageName:
09 The Synflorix Incident: The Aftermath


pageName:
11 The Sponsor, the Study Participant, and the Sit


pageName:
1 - A closer look at your applications (menu)


pageName:
2 - A closer look at your applications: Your appli


pageName:
Expected energy allocation details report


pageName:
Show what you know - Uninstructed Imbalance energy


pageName:
show what you know - Instructed Imbalance energy


pageName:
Show what you know - Locational Marginal Price


pageName:
show what you know - Settlements Business Practice


pageName:
show what you know - Expected energy allocation de


pageName:
show what you know - Marginal Cost of Congestion


pageName:
show what you know - Marginal Cost of losses


pageName:
show what you know - Greenhouse gas component


pageName:
results: Instructed Imbalance energy def


pageName:
results: Uninstructed Imbalance energy def


pageName:
03 - Why Preparing for Site Evaluation Matters


pageName:
4 Safety Information and Product Handling


pageName:
2 Find the Screen- Alarm Volume and Tone


pageName:
3 Find the Screen- Drug and Dosing Information


pageName:
1 New System Implant Programming Timeline


pageName:
12 New System Implant Programming Review


pageName:
04 - Ask the Site - Existing Site Question


pageName:
06 - Ask the Site - Existing Site Question


pageName:
10 - Ask the Site - Existing Site Question


pageName:
13 - Ask the Site - Existing Site Debrief


pageName:
04 How Site Qualification is Like Choosing a Physi


pageName:
23 - Review Site Information - Robust Feasibility


pageName:
03 - Gather Information - Your Resources


pageName:
05 - Use your Resources: External Resources


pageName:
09 - Use Your Resources; Debartment Lists


pageName:
10 - Use Your Resources; Internal Resources


pageName:
11 - Use Your Resources; Internal Resources


pageName:
06: Resource-specific versus global issues


pageName:
09: Knowledge check (resource-specific) - 1


pageName:
10: Knowledge check (resource-specific) - 2


pageName:
11: Knowledge check (resource-specific) - 3


pageName:
12: Knowledge check (resource-specific) - 4


pageName:
13: Global resources troubleshooting guidelines


pageName:
02: Introduction to resource-specific scenario


pageName:
24: Introduction to global outage scenario


pageName:
5: Trial-Specific Topics in other sections


pageName:
4.12 View/export settlements (q 2 of 2) main


pageName:
4.12 View/export settlements (q 2 of 2) correct


pageName:
4.12 View/export settlements (q 2 of 2) incorrect


pageName:
4.12 View/export settlements (q 2 of 2) correct 1,


pageName:
4.12 View/export settlements (q 2 of 2) scenario


pageName:
4 How Documenting Site Selection is like School


pageName:
2-Change Trial-Specific Contact Information in Tri


pageName:
1-Trialforce - Investigator Site Change Form


pageName:
03: EIM market timing and charge codes - main scre


pageName:
03a: EIM market timeline and charge codes-T+75 (la


pageName:
03b: EIM market timeline and charge codes-T+40 (la


pageName:
03c :EIM market timeline and charge codes-T+37.5 (


pageName:
03d: EIM market timeline and charge codes-T+7.5 (l


pageName:
03e: EIM market timeline and charge codes-Flexible


pageName:
03f: EIM market timeline and charge codes- UFE


pageName:
03g: EIM market timeline and charge codes-Flexible


pageName:
03h: EIM market timeline and charge codes-Grid Man


pageName:
03i: EIM market timeline and charge codes - Foreca


pageName:
04: Pre-market validation charge codes overview


pageName:
06: Market results charge codes overview


pageName:
07: Market results charge codes (FMM IIE)


pageName:
08: Market results charge code  (Real-time IIE)


pageName:
08: Market results charge codes (Flex ramp)


pageName:
10: Meter results charge codes (Offsets)


pageName:
12: Administrative charge codes (Admin fees)


pageName:
03q: EIM Market timeline and charge codes - BCR


pageName:
4: Choosing the Right Tool - sale in process


pageName:
31: Which market conditions (drap and drop)


pageName:
54: Which market conditions (drag and drop)


pageName:
10: Which market conditions (drag and drop)


pageName:
007: Introduction to Reagent Preparation


pageName:
008: Introduction to Reagent Preparation (2)


pageName:
011: See the Components Temperature Controlled


pageName:
018: Try it: Match Barcodes_Refrigerated


pageName:
Scenario 1: Other charge codes that apply (1.2)


pageName:
Scenario 2: Other charge codes that apply (1.5)


pageName:
Scenario 4: Other charge codes that apply


pageName:
Scenario 5: What other charge codes apply? (1.10)


pageName:
03a: Explore Product Specifications Sheet - sectio


pageName:
03b: Explore Product Specifications Sheet - sectio


pageName:
03c: Explore Product Specifications Sheet - sectio


pageName:
03d: Explore Product Specifications Sheet - sectio


pageName:
02a: Warehouse tour 1- Product 1 (layer)


pageName:
02b: Warehouse tour 1- Product 2 (layer)


pageName:
02c: Warehouse tour 1- Product 3 (layer)


pageName:
03a: Warehouse tour 2 - Product 1 (layer)


pageName:
03b: Warehouse tour 2 - Product 2 (layer)


pageName:
03c: Warehouse tour 2 - Product 3 (layer)


pageName:
05a: The Decision - scenario (choice 1 layer)


pageName:
05b: The Decision - scenario (choice 2 layer)


pageName:
07a: What's the plan? (assessment layer)


pageName:
07b: What's the plan (implementation layer)


pageName:
02a: Trial Change Mgt Process (identify layer)


pageName:
02b: Trial Change Mgt Process (investigate layer)


pageName:
02c: Trial Change Mgt Process (approve layer)


pageName:
02d: Trial Change Mgt Process (revise layer)


pageName:
04: What does it mean to me? (case study 1)


pageName:
07: What does it mean to me? (case study 2)


pageName:
10: What does it mean to me? (case study 3)


pageName:
13: A Clarification to Protocol - Best practices


pageName:
01: A Change to Collect Times Introduction


pageName:
13: A Change to Collect Times - Best practices


pageName:
2.1 An Overview of the Clinical Trial Systems


pageName:
2.5 Who's Responsible for IMPACT Information?


pageName:
2.6 Using the Trial-Specific Collaboration Site


pageName:
2.8 The Trial-Specific Collaboration Site Process


pageName:
3.3 Managing a Trial: IMPACT (2) Feedback


pageName:
3.4 Managing a Trial: IMPACT (3) Feedback


pageName:
3.6 Managing a Trial: IMPACT (5) Feedback


pageName:
3.7 Managing a Trial: Collaboration Site (1)


pageName:
3.8 Managing a Trial: Collaboration Site (2)


pageName:
3.8 Managing a Trial: Collaboration Site (2) Feedb


pageName:
3.9 Managing a Trial: Collaboration Site (3)


pageName:
3.9 Managing a Trial: Collaboration Site (3) Feedb


pageName:
3.10 Managing a Trial: Collaboration Site (4)


pageName:
2.7 The TMF and Trial Collaboration Sites


pageName:
5 - Title Placeholder - Top Competitors Introducti


pageName:
9- Title Placeholder - Top Competitors Introducti


pageName:
10 - Title Placeholder - Top Competitors


pageName:
02: Verify Member Information screenshot


pageName:
Get to know the customers - single owner


pageName:
Get to know the customers - Senior Living Facility


pageName:
Get to know the customers - Small Business Owner


pageName:
Get to know the customers - property owner


pageName:
3.14 (pi!) Decision drivers (apartment owner)


pageName:
3.15 Explain the value (apartment owner)


pageName:
02: When Do Clinical Trial Mgt Process Apply?


pageName:
03: Who is Responsible for Clinical Trial Mgt?


pageName:
04: What is Included in Clinical Trial Management?


pageName:
06: Requirements for Clinical Trial Management


pageName:
09: Requirements for Set Up Trial Meetings


pageName:
12: Requirements for Notify Required Personnel


pageName:
14: Manage Trial Level Communications Scenario


pageName:
15: Requirements for Manage Trial Level Communicat


pageName:
16: Manage Trial Level Communications Review


pageName:
08: Purpose of Notify of Approved Records


pageName:
09: Purpose of Communications and Templates


pageName:
2.1b Complete & Distribute Trial-Level Templates


pageName:
2.1c Manage Trial Communications & Documentation


pageName:
2.1g Develop & Manage Consulting Agreements


pageName:
2.1h Notify Personnel of Availability of Approved


pageName:
2.1 An Overview of the Clinical Trial Activities


pageName:
2.5 The Build is Almost Complete...part 1-1


pageName:
2.8 The Build is Almost Complete...part 1-2


pageName:
2.19 The Build is Almost Complete...part 1-3


pageName:
2.20 The Build is Almost Complete...part 1-4


pageName:
2.6 The Build is Almost Complete...part 2-1


pageName:
2.7 The Build is Almost Complete...part 2-2


pageName:
2.18 The Build is Almost Complete...part 2-3


pageName:
7 Location of ICF Templates, Checklists and Resour


pageName:
7 Reviewing and Approving Site Level ICFs


pageName:
4.2a: How does paralleling work? (loadshare1)


pageName:
4.2b: How does paralleling work? (loadshare2)


pageName:
4.2c: How does paralleling work? (penny2)


pageName:
4.2d: How does paralleling work? (loadgov1)


pageName:
4.2e: How does paralleling work? (loadgov2)


pageName:
4.3: Paralleling Configuration Review - q1


pageName:
4.4: Paralleling Configuration Review - q2


pageName:
4.5: Paralleling Configuration Review - q3


pageName:
4.6: Paralleling Configuration Review - q4


pageName:
5.2: Key Milestone in Paralleling (main)


pageName:
5.2a: Key Milestone in Paralleling- traditional


pageName:
5.2b: Key Milestone in Paralleling - digital proce


pageName:
5.2c: Key Milestone in Paralleling - modern


pageName:
6.1: Products that do not support paralleling


pageName:
7.3: Where can I get more information -1


pageName:
7.4: Where can I get more information? -2


pageName:
Finalize and Manage Informed Consent Content


pageName:
Finalize and Manage Informed Consent Content mls 1


pageName:
Finalize and Manage Informed Consent Content mls 2


pageName:
3.6a: Paralleling Conditions Review -penny1


pageName:
3.6b: Paralleling Conditions Review - penny2


pageName:
3.6c: Paralleling Conditions Review - penny3


pageName:
3.6d: Paralleling Conditions Review - penny4


# Releases

releaseNo:
NCAA Developing Leaders for Life Client Alpha


releaseNo:
Cummins: Leadership Essentials - Internal Alpha


releaseNo:
Cummins: Leadership Essentials - External Alpha


releaseNo:
Cobas 4800Virology - Infiltrate The Competition IA


releaseNo:
Roche Middleware Module 8 SEL - Internal Alpha


releaseNo:
Middleware 3b - SM Workspace Intermediate - IA


releaseNo:
Cummins- Program Orientation Internal GM Review 2


releaseNo:
6000 reTool - Customer Connections - EDP


releaseNo:
cobas IT 1000 competencies IB no captivates


releaseNo:
Harlan Learning Checkpoints - Internal Alpha


releaseNo:
Cummins OneSource Navigation - Internal Beta2


releaseNo:
Roche - HE600 Learning Checks - IA_edits


releaseNo:
cobas IT 1000 App Overview internal GM no cap


releaseNo:
VENTANA HE 600 Troubleshooting Library ALPHA


releaseNo:
Cummins: Leadership Essentials - Internal Beta


releaseNo:
Cummins: Leadership Essentials - External Beta


releaseNo:
Cummins: QuickServe - Portuguese Internal


releaseNo:
Cobas 4800Virology - Infiltrate The Competition EA


releaseNo:
VENTANA HE 600 - Story Pillars: Internal Alpha2


releaseNo:
VENTANA HE 600 - Story Pillars: Externall Alpha


releaseNo:
Cummins OneSource Navigation - Internal Beta


releaseNo:
Middleware 3B - System Maintenance - IA 2


releaseNo:
Cummins OneSource Navigation - Internal Beta3


releaseNo:
Middleware 3b - SM Workspace Intermediate - EA


releaseNo:
Cummins CSO Communication External Prototype


releaseNo:
Harlan Learning Checkpoints - Internal Beta


releaseNo:
Cummins: QuickServe - Portuguese External


releaseNo:
Roche - IVD Regulations Overview: External Alpha


releaseNo:
IAP - Data Classification Alpha - Internal


releaseNo:
IAP-Data Classification - External Alpha


releaseNo:
IAP - Data Classification Beta - Internal


releaseNo:
IAP - Data Classification Beta - External


releaseNo:
IR Rebrand: Wave 1 - Electrified Hardware: Externa


releaseNo:
IR Rebrand: Wave 1 - Exit Device Workout: External


releaseNo:
cobas 6888 - final challenge design proof


releaseNo:
cobas 6888 - intro design proof (external)


releaseNo:
cobas 6888 - workflow design proof (external)


releaseNo:
cobas 6888 - final challenge design proof (externa


releaseNo:
cobas 6888 - Lab of Tomorrow (internal beta)


releaseNo:
cobas 6888 - Lab of Tomorrow (external beta)


releaseNo:
cobas 6888 - Finalizing the Grid Alpha (internal)


releaseNo:
cobas 6888 Finalizing the Grid (External Alpha)


releaseNo:
Cummins OneSource Navigation External Beta


releaseNo:
Cummins OneSource Navigation Internal GM


releaseNo:
B3 - Boost the Connection: Internal Alpha


releaseNo:
B3 - Boost the Connection: External Alpha


releaseNo:
Roche - RegAffairs IT Emag - Internal Alpha


releaseNo:
Roche - RegAffairs IT Emag - Internal Alpha2


releaseNo:
Roche - RegAffairs IT Emag - External Alpha


releaseNo:
Cummins - Finance for HR: Internal Alpha


releaseNo:
Cummins - Finance for HR: External Alpha


releaseNo:
Cummins - Fuel Economy 101: internal alpha


releaseNo:
Cummins - Fuel Economy 101: external alpha


releaseNo:
Supercuts Mobile App Training - Client Alpha


releaseNo:
Roche Middleware Module 10 - Internal Alpha


releaseNo:
Roche Cobas 4800 - GRFT Design Proof Internal Alph


releaseNo:
Roche Cobas 4800 - GRFT Design Proof External Alph


releaseNo:
Roche Cobas 4800 - GRFT - Internal Alpha


releaseNo:
Roche Cobas 4800 - GRFT - External Alpha


releaseNo:
VENTANA HE 600 Troubleshooting Library design proo


releaseNo:
Roche Middleware Module 10 - Internal GM


releaseNo:
Middleware 3b - SM Workspace Intermediate - IGM


releaseNo:
cobas 6000 Learning Checkpoints Days 1-4


releaseNo:
cobas 6000 Learning Checkpoints-Beta (Internal)


releaseNo:
cobas 6000 Learning Checkpoints-Beta (External)


releaseNo:
Hybrid Online Orientation External Alpha


releaseNo:
Roche Cobas 6000 Onsite App - External Alpha


releaseNo:
Cummins Intro to HR - Spanish Translation


releaseNo:
Roche Cobas 6000 Onsite App - External Beta


releaseNo:
VENTANA - HE 600 Cave of needs: External Alpha


releaseNo:
cobas4800 - Infiltrate The Competition - IDP


releaseNo:
cobas4800 - Infiltrate The Competition - ExternalD


releaseNo:
Cobas 4800Virology - Workflow Module - IDP


releaseNo:
Cobas 4800Virology - Workflow Module - IA


releaseNo:
cobas4800 - The Power of Planning - External DP


releaseNo:
Cobas 4800Virology - Workflow Module - IDP2


releaseNo:
Cobas 4800Virology - Workflow Module - EDP


releaseNo:
Patient Experience Survey Internal Alpha


releaseNo:
Patient Experience Survey - Internal Alpha 2


releaseNo:
Cobas 4800Virology - Workflow Module - EA


releaseNo:
Cobas 4800Virology - Infiltrate The Competition IG


releaseNo:
Cobas 4800Virology - Workflow Module - EGM


releaseNo:
Introduction to Allegion in the U.S. Market - Inte


releaseNo:
Introduction to Allegion in the U.S. Market - Exte


releaseNo:
Roche - Path to Slide Success Internal Alpha


releaseNo:
Roche - Path to Slide Success Internal Beta


releaseNo:
cobas 6888 - Lab of Tomorrow (new project)


releaseNo:
Roche - Path to Slide Success Internal GM


releaseNo:
RMS - Transplant Academy - Course 1 - EDP


releaseNo:
Lilly NGD: Creating Country and Site ICFs IGM


releaseNo:
Lilly NGD: Creating Country and Site ICFs GM


releaseNo:
VENTANA HE 600 Onsite App Internal Alpha


releaseNo:
Salesforce - Social Studio: Course 2 - Internal Al


releaseNo:
MISO Access Managment Design Proof internal alpha


releaseNo:
Salesforce - Social Studio: Course 2 - Alpha


releaseNo:
Cummins- Program Orientation Internal Review


releaseNo:
Roche Middleware Mod 6 - Internal review


releaseNo:
Cummins- Program Orientation External Review


releaseNo:
Salesforce - Social Studio: Course 2 - External


releaseNo:
Roche Middleware Mod 6 - External review


releaseNo:
Roche Middleware SM Workspace-Users Alpha Internal


releaseNo:
Roche Middleware SM Workspace-Users Alpha External


releaseNo:
Salesforce - Social Studio: Course 2 - GM


releaseNo:
Roche Middleware SM Workspace Users - IA2


releaseNo:
Salesforce - Social Studio: Course 3 internal alph


releaseNo:
Salesforce - Social Studio: Course 3 alpha


releaseNo:
Cummins- Program Orientation Internal GM Review


releaseNo:
Cummins OneSource Navigation - Internal Alpha


releaseNo:
Cummins OneSource Navigation - External Alpha


releaseNo:
Middleware 5 - Rules Interface Overview - IA


releaseNo:
Roche Middleware Module 17 -Internal Alpha


releaseNo:
Middleware 5 - Rules Interface Overview - EA


releaseNo:
cobas IT 1000 User Management design proof interna


releaseNo:
Middleware 5 - Rules Interface Overview - IGM


releaseNo:
cobas IT 1000 Application Overview design proof


releaseNo:
Roche Middleware Module 17 - internal GM


releaseNo:
cobas IT 1000 User Management design proof


releaseNo:
cobas IT 1000 Application Overview External Design


releaseNo:
Roche Middleware Module 18 - Internal Alpha


releaseNo:
Middleware 6 - Rules Writing Intermediate - IA


releaseNo:
Middleware 6 - Rules Writing Intermediate - EA


releaseNo:
Middleware 6 - Rules Writing Intermediate - IGM


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - IDP


releaseNo:
Cobas 6000 - Get Ready for Install - IDP


releaseNo:
cobas IT 1000 Certification Next - Alpha


releaseNo:
cobas IT 1000 competencies Alpha 04/27/2016


releaseNo:
6000 reTool - Customer Connections - IDP


releaseNo:
Roche HE 600 Troubleshooting Library Internal Alph


releaseNo:
MEDRONIC Implant Practice Internal Design Proof


releaseNo:
6000 reTool - Customer Connections - EGM


releaseNo:
Medtronic: Get Ready for RIS - Design Proof


releaseNo:
6000 reTool - Customer Connections - IGM


releaseNo:
cobas IT 1000 Certification Basics Internal Beta 2


releaseNo:
cobas IT 1000 Competencies Internal Beta 2.0


releaseNo:
cobas IT 1000 Certification Basics Beta 2.0


releaseNo:
cobas IT 1000 Certification Next Steps Beta 2.0


releaseNo:
MDT: New Implant Programming Design Proof


releaseNo:
Cobas 6000 - Get Ready for Install - EDP


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - DP


releaseNo:
RMS 6888 Ready to Compete - Internal ALPHA


releaseNo:
cobas IT 1000 Server Administration Alpha


releaseNo:
RMS 6888 Ready to Compete - Internal ALPHA 2


releaseNo:
cobas IT 1000 Certification Basics Internal GM


releaseNo:
Healthy Families America: Know Your Personal Belie


releaseNo:
Medtronic: Get Ready for RIS - New Section iDP


releaseNo:
HFA: Infant and Childhood Development Prototype


releaseNo:
HFA: Infant and Childhood Development Prototype 2


releaseNo:
CAISO - 8 - Metering foundational concepts - IA


releaseNo:
cobas IT 1000 Server Administration Internal Beta


releaseNo:
RMS - Ready to Compete - internal Beta 1


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - IA


releaseNo:
cobas IT 1000 Server Administration Beta


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - EA


releaseNo:
Lilly NGD: Vendor Budgets and Contracts IB


releaseNo:
cobas IT 1000 Drivers Clinitek Internal Alpha


releaseNo:
Lilly NGD: Managing Site Information Comic Activit


releaseNo:
Lilly NGD Select Sites Activity Sample 0907


releaseNo:
Medtronic: Implant in Practice Int. Alpha 2


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - IB


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - EB


releaseNo:
Medtronic: Get Ready for RIS - iAlpha_2.1


releaseNo:
Lilly NGD: Managing Site Overview Comic Activity


releaseNo:
Lilly NGD: Managing Sites Overview Alpha


releaseNo:
Lilly NGD: Managing Sites Overview Alpha New


releaseNo:
Lilly NGD Creating a ClinPharm ICF animation test


releaseNo:
Lilly NGD: Closing Out Sites Incomplete IA


releaseNo:
Lilly NGD Review Site generated content IA2


releaseNo:
Lilly NGD Creating a ClinPharm ICF Alpha


releaseNo:
Cobas 6000 - Get Ready for Install - iGM


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - iGM


releaseNo:
MISO Deep Dive: CTP Communication Alpha2


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - GM


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC -IA 1


releaseNo:
Lilly NGD:Dev Site Activation Enrollment Alpha


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC -IA 2


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - Alpha


releaseNo:
Cobas 6000 - Get Ready for Install - GM2


releaseNo:
Cobas 6000 - Get Ready for Install - GM3


releaseNo:
Cobas 6000 - Get Ready for Install - GMfinal


releaseNo:
Cobas 6000 Get Ready for Troubleshooting - GM/Audi


releaseNo:
Roche - Becoming an FES Coach - Internal Alpha


releaseNo:
Lilly NGD: Vendor Budgets and Contracts IA


releaseNo:
Roche - Becoming an FES Coach - Internal Alpha (AG


releaseNo:
Lilly NGD: Selecting Sites Overview Alpha


releaseNo:
Lilly NGD: Vendor Budgets and Contracts IA2


releaseNo:
Lilly NGD: Selecting Sites Overview Alpha 2


releaseNo:
Lilly NGD: Vendor Budgets and Contracts Alpha


releaseNo:
Roche - Becoming an FES Coach - Internal Alpha Fin


releaseNo:
Roche - Becoming an FES Coach - External Alpha


releaseNo:
Lilly NGD: Dev Site Act and Enrollment Beta


releaseNo:
Lilly NGD: Recruit Part and Manage Enrollment IB


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - iBeta


releaseNo:
Lilly NGD: Selecting Sites Overview iBeta


releaseNo:
Lilly NGD: Recruit Part and Manage Enrollment Beta


releaseNo:
Lilly NGD: Selecting Sites Overview Beta


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - Beta


releaseNo:
Lilly NGD: Vendor Budgets and Contracts Beta


releaseNo:
RMS - Microbiology Course 2 - Alpha - Part2


releaseNo:
Lilly NGD Developing Effective PS Training iA


releaseNo:
RMS - Microbiology Course 2 - Alpha - Part3


releaseNo:
Lilly NGD: Creating Country and Site ICFs IA2


releaseNo:
Lilly NGD: Manage Site Information Overview IGM


releaseNo:
Roche - Becoming an FES Coach - Int_Beta


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - iGM


releaseNo:
Lilly NGD: Manage Site Information Overview GM


releaseNo:
Lilly NGD: Dev Site Act and Enrollment GM


releaseNo:
Lilly NGD: Rec Part and Manage Enrollment GM1


releaseNo:
Lilly NGD: Dev Effective PS Training Alpha


releaseNo:
Lilly NGD: Qualifying Sites with HP-SEC - GM


releaseNo:
Lilly NGD: Writing An Accurate TCED External Alpha


releaseNo:
Roche - FES Coach Course - External Beta


releaseNo:
Lilly Negotiating Exceptions Audio Edits


releaseNo:
Lilly NGD: Write Accurate TCED Alpha 1 INT


releaseNo:
Lilly NGD: Rec Part and Manage Enrollment GM2


releaseNo:
Lilly NGD: Dev Site Act and Enrollment Final GM


releaseNo:
Lilly NGD: Vendor Budgets and Contracts IGM


releaseNo:
Lilly Negotiating Exceptions igm (no audio)


releaseNo:
Lilly NGD: Vendor Budgets and Contracts GM


releaseNo:
Lilly NGD: Dev Effective PS Training iA2


releaseNo:
Lilly NGD: Creating Country and Site ICFs IA


releaseNo:
Cummins Information Fuels the Business - External


releaseNo:
Lilly NGD: Creating Country and Site ICFs Alpha


releaseNo:
CAISO - 21 - Settlements alpha - Int Alpha


releaseNo:
Lilly siteSelection: Site Evaluation ERB DesignPro


releaseNo:
RMS - Microbiology Course 2 - Beta - Proofer


releaseNo:
Lilly NGD: Creating Country and Site ICFs A2


releaseNo:
Lilly NGD: Creating Country and Site ICFs IB


releaseNo:
Lilly NGD: Dev Effective PS Training IGM


releaseNo:
Lilly NGD: Creating Country and Site ICFs Beta


releaseNo:
RMS - Transplant Academy - Course 1 - IA


releaseNo:
RMS - Transplant Academy - Course 1 - EA


releaseNo:
RMS - Transplant Academy - Course 1 - EA - New


releaseNo:
Cummins CSO Careful Communication Vignettes - iDP


releaseNo:
Cummins CSO Careful Communication Vignettes - DP


releaseNo:
Lilly NGD: Creating Country and Site ICFs Final IG


releaseNo:
Cummins CSO Careful Communication Vignettes - Alph


releaseNo:
RMS - Transplant Academy - Course 1 - IB


releaseNo:
Lilly NGD Qualify and Select Sites - ipAlpha


releaseNo:
RMS - Transplant Academy - Course 1 - EB


releaseNo:
Lilly NGD Qualify and Select Sites - Prealpha


releaseNo:
Lilly NGD Qualify and Select Sites - ialpha


releaseNo:
Lilly NGD Qualify and Select Sites - Alpha


releaseNo:
Lilly NGD Managing Satellites - prealpha


releaseNo:
RMS - Transplant Academy - Intro Animation - EB


releaseNo:
******Workflow App - Popup Text Final Edits


releaseNo:
RMS - Transplant Academy - Intro Animation - EGM


releaseNo:
RMS - Transplant Academy - Course 1 - IGM


releaseNo:
RMS - Transplant Academy - Course 1 - EGM


releaseNo:
RMS - Transplant Academy - Course 4 - IA


releaseNo:
RMS - Transplant Academy - Course 4 - IA2


releaseNo:
RMS - Transplant Academy - Course 4 - EA


releaseNo:
RMS - Transplant Academy - Course 4 - IB


releaseNo:
RMS - Transplant Academy - Course 4 - EB


releaseNo:
Lilly Trial - Consulting Agreements- iAlpha


releaseNo:
RMS - Transplant Academy - Course 4 - EGM


releaseNo:
Lilly Trial - Consulting Agreements- Alpha


releaseNo:
*******************Roche cobas 8000 Learning Check


releaseNo:
Mosaic - Visual Inspection Proceedures_IDP1


releaseNo:
Cummins - SalesForce - RLC Understanding Customer


releaseNo:
Mosaic - Visual Inspection Proceedures - EDP


releaseNo:
Lilly Trial - Consulting Agreements- iBeta


releaseNo:
Lilly - CTAS Financial Disclosure External Beta


releaseNo:
Lilly Trial - Consulting Agreements- Beta


releaseNo:
Lilly Trial - Consulting Agreements- iGM


releaseNo:
RMS TV/MG: Casting Call Alpha Internal 20170628


releaseNo:
RMS TV/MG: Casting Call Alpha External 20170705


releaseNo:
Ventana Converting From Competitors - IDP


releaseNo:
Ventana Converting From Competitors - EDP


releaseNo:
Cummins - SF - Course9_Paralleling_intDP


releaseNo:
Ventana Understanding Our Customers - EDP


releaseNo:
Cummins - SF - Course9_Paralleling_internalAlpha


# Sections

sectionName:
Choose Your Division or Conference Office


sectionName:
Cred Case Studes: Update An Aging Facility


sectionName:
What Makes Smart Cards: Syst Compatibility


sectionName:
What Makes Smart Cards: Assess Your Need


sectionName:
Making A Smart Choice: Talking to Others


sectionName:
Making A Smart Choice: Compatibility Concerns


sectionName:
Making A Smart Choice: Migration Concerns


sectionName:
510(k) Submissions and Predicate Devices


sectionName:
Process Green Rack and Daily Hands On Maintenance


sectionName:
Prepare and Load Calibrators and Controls


sectionName:
Verify and Record Photometer Check Values


sectionName:
Initiate a Run of Calibrators and Controls


sectionName:
Every 2 Months and Quarterly Maintenance


sectionName:
Use MyLabOnline, cobas link, and cobas e-Library


sectionName:
Follow Your Learning Path - Key Operator


sectionName:
Common Challenges with Grossing and Processing


sectionName:
Tasks completed during Operation or Stand By


sectionName:
cobas 8000 with ref. 2 - continue button


sectionName:
cobas 8000 without ref. 2 - continue button


sectionName:
cobas 6000 with ref. 2 - continue button


sectionName:
cobas 6000 without ref. 2 - continue button


sectionName:
Collecting Information & Researching Resources


sectionName:
Importance of Early Stage Requirements Gathering


sectionName:
Turning Good Requirements into Great Requirements


sectionName:
Roche Middleware Solutions and Out of Service


sectionName:
Demo: Twitter Use Case - Service Console


sectionName:
Processing Plates, Cassettes, and Amplification Plates


sectionName:
Behavioral, Cognitive, and Socio-emotional Struggles


sectionName:
Build Your Implantable System for Remodulin Team


sectionName:
Asking Probing Questions - Customer Convo


sectionName:
Tasks Performed During Operation or Stand By


sectionName:
Scenarios - 03 Bid/base schedule submitter


sectionName:
Scenarios - 09 User access administrator


sectionName:
Whats the right application? (Questions)


sectionName:
PI Recruiting Study Participants From Other Offices


sectionName:
PI and Sub-Investigator in Two Locations


sectionName:
Medical Research Agreement Versus Other Agreements


sectionName:
Competitive Landscape Key Market Drivers


sectionName:
How Does the Product Match the Customer Needs?


